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Leishmaniasis is a neglected tropical disease and a major cause of morbidity and 
mortality in impoverished countries.  Leishmaniasis is a global disease and is clinically 
and epidemiologically diverse, with many different species of Leishmania affecting 
humans.  The aim of this study was to investigate the classification of L. tropica and L. 
aethiopica as different species, and to check for the presence of LRV in their isolates.  
L. tropica and L. aethiopica are closely related species of Leishmania that infect 
humans; and there is some debate over whether they are indeed different species.  The 
Leishmania RNA Virus is a double stranded RNA virus which infects Leishmania and 
is thought to increase the pathology of the disease and exacerbating mucosal 
developments.  The methods used in this study were polymerase chain reaction and 
sequencing for the ITS1 gene and a dot blot to detect the presence of LRV.  The results 
of the PCR were used for identification, the formation of phylogenetic trees, and a 
distance pairwise matrix.  The PCR results supported the classification of L. tropica 
and L. aethiopica as different species, supporting previous results also used for the 
analysis.  The results of the dot blot found LRV presence in the L. aethiopica isolates 
but no evidence of the virus in L. tropica.  The identification of an infecting species of 
Leishmania and the clinical outcomes it can cause will help provide appropriate and 
affective treatment.  The findings of this study also demonstrate the importance of 
species identification and the methods used. 
1 
 
Chapter One: General Introduction 
1.1. Leishmania and Leishmaniasis 
Leishmaniasis is "a neglected vector-borne tropical infection that is considered to be a 
disease of poverty" (Pace, 2014).  An infectious disease is considered to be neglected 
when there is the absence of effective, affordable or accessible drug treatments.  The 
demographic population for such diseases tend to be poor, living in developing 
countries, and so are often ignored by the pharmaceutical industry (Yamey, 2002).  
However, the increase in international travel has also led to an increase in the number 
of leishmaniasis cases in non-endemic countries (Field et al. 2010).  This makes the 
parasitic infection even more important to address. 
Leishmaniasis is a protozoal infection.  Although well recognised, the disease has been 
shrouded in various mysterious names for a long time; such as Dumdum fever and kala-
azar, meaning “black fever” in Hindi.  The disease was first described in 1903 by 
Leishman and Donovan (Murray, 2002).  Leishmaniasis is clinically and 
epidemiologically diverse, and has some of the highest morbidity and mortality rates 
amongst parasitic diseases.  The disease can lead to various clinical manifestations, 
from localised skin ulcers to a lethal systemic disease.  Cutaneous leishmaniasis is a 
vector-borne parasitic disease that is transmitted by the bite of sand flies.  This disease 
results in one or more sores or nodules on the skin that frequently heal without treatment 
after a few months, but often resulting in scar formation.  Cutaneous leishmaniasis is 
the most widely distributed manifestation of leishmaniasis (Kebede et al. 2013).  





Figure 1.1 Phylogeny of Leishmania. Analysis of 21 species of Leishmania is shown, 
including 11 medically important species shown in Table 1.1.  Grouping into subgenera (as of 
2015) is also shown.    A: Subgenus Leishmania; B: Sugenus Sauroleishmania; C: Subgenus 
Viannia; Crithidia fasciculata was used as the outgroup. Source: Bates, 2015. 
Leishmaniasis is caused by over 20 different species of the genus Leishmania, as seen 
in Figure 1.1.  Leishmania parasites are obligate intracellular protozoan parasites that 
are transmitted via the bite of an infected sand fly to their mammalian hosts, including 
humans.  The Leishmania parasites are trypanosomatid protozoans, in which the 
parasite predominately infects the macrophages of the mammalian host (Weigle and 
Saravia, 1996).  The parasitic disease affects both adults and children (Murray, 2002).  
The parasite is endemic in countries with a tropical or sub-tropical climate; and there is 
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variation in the species found across the various geographic locations.  The 
classification of Leishmania into its subgenera, as seen in Figure 1.1, is based on the 
anatomical differences of the sites of parasite development in the gut of their sand fly 
hosts.  The two main subgenera relevant to human disease are the New World L. 
Viannia, and the Old World L. Leishmania; New World parasites are found in the 
Americas and the Old World parasites are found across Asia, Africa and Europe (Pace, 
2014).  However, new research has proposed the existence of a new subgenus, 
Leishmania (Mundinia), including the species L. enriettii and some newly described 
species causing human disease in Ghana and Thailand (Espinosa et al. 2016).  The 
epidemiologic features of the disease and appropriate control measures depend many 
factors.  These include the geographic location, the infecting species of Leishmania, the 
reservoir host, and the biological aspects of the vectors (Bern et al. 2008).  Factors that 
are associated with an increased risk of the disease progressing include malnutrition 
and a compromised immune system (Guerin et al. 2002); this means that the disease 
has a disproportional effect on the poor, and that immunocompromised individuals such 
as human immunodeficiency virus (HIV) patients have a higher risk of the disease.  
















































































































































































































































Source: Bates, 2015 
1.2. The life cycle of Leishmania 
The survival of the Leishmania parasite is dependent on successful transmission; 
zoonotic or anthroponotic; between the sand fly vector and mammalian reservoir (Pace, 
2014).  Leishmaniasis can be transmitted to humans in sylvatic, domestic or 
peridomestic cycles (Bern et al. 2008). The mammalian hosts and vectors responsible 
for transmission of some medically important species of Leishmania are shown in Table 
1.1.  Transmission of the parasite may follow an anthroponotic or zoonotic cycle, and 
this can vary by region.  Anthroponotic transmission often occurs in urban areas via the 
bite of phlebotomine sand flies (Jacobson, 2013), and accounts for the largest number 
of human cases of leishmaniasis (Reithinger et al. 2003). In contrast, animals are the 
main reservoirs in rural areas with a zoonotic life cycle (Jacobson, 2013).  Zoonotic 
transmission of the Leishmania parasite occurs in both domestic and sylvatic cycles.  In 
domestic cycles the major reservoir is the dog.  Sylvatic cycles occur in areas such as 
the rain forests of South America, whereas enzootic transmission occurs between wild 
animals in the deserts of Central Asia.  In these cycles humans are a “dead end” host of 
the infection; however, the animal reservoir hosts can maintain enzootic transmission 
indefinitely without the human disease.  For kala-azar and post kala-azar leishmaniasis 
(PKDL) humans are believed to be the sole reservoir in these anthroponotic cycles.  




Figure 1.2 Life Cycle of Leishmania. Source: Centers for Disease Control and Prevention. 
(2013). Parasites – Leishmaniasis: Biology. [online] Available at: 
 https://www.cdc.gov/parasites/leishmaniasis/biology.html. [Accessed June 30, 2017]. 
The skin is the point of entry for the Leishmania parasite (Murray, 2002) via the bite of 
the sand fly, as shown in Figure 1.2.  There are two major morphological forms in the 
life cycle of Leishmania, as seen in Figure 1.3.  One is an extracellular flagellated 
promastigote, which is 15-20µm long and found within the sand fly (Bates, 2008).  The 
other is an obligate intracellular non-flagellated amastigote.  It is 3-5µm long and found 




Figure 1.3 Developmental Forms of Leishmania. The two developmental form of 
Leishmania. Each form has a nucleus and kinetoplast in the single mitochondrion.  The 
flagellum arises from the flagellar pocket. Source: Bates, 2015. 
When infected with the Leishmania parasite, the spleen, liver, and bone marrow 
macrophages are selectively parasitized and support intracellular replication.  The 
lymph nodes and skin are rarely involved (Murray, 2002).  Amastigotes develop and 
multiply in the phagocyte cell until they are released by cell lysis in order to infect other 
macrophages (Hommel, 1999).  Intracellular amastigotes are also known as Leishman-
Donovan bodies, particularly in diagnostic tropical medicine.  The typical characteristic 
of Leishman-Donovan bodies is the kinetoplast, a structure that consists of 
mitochondrial DNA, which can be seen staining separately from the Leishmania 
nucleus in infected clinical specimens.  After being ingested by the sand fly from a 
blood meal the amastigotes re-transform back into flagellated promastigotes.  In vitro 
cultures of samples can be used to grow these promastigotes.  The samples can be taken 
from infected humans, sandflies, or animal reservoirs (Santarém et al. 2014).  Specific 
antibodies against the infection do develop, but they do not provide significant 





fp: flagellar pocket 
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Genetic exchange of strains of Leishmania is believed to occur inside the female sand 
fly vector. The diversity of Leishmania species is thought to have mainly arisen due to 
the gradual accumulation of divergent mutations rather than by sexual recombination; 
however, there is a growing number of examples of naturally occurring strains of 
Leishmania that share genotypic markers from two recognised species.  This provides 
circumstantial evidence for the occurrence of sexual recombination (Akopyants et al. 
2009).  Genetic exchange has been observed in other trypanosmatids which cause 
disease in humans, such as Trypanosoma brucei (Jenni et al. 1986).  It has been 
observed (Akopyants et al. 2009) that Leishmania can undergo genetic exchange during 
growth and development when in the sand fly vector, and infectious-stage hybrid 
progeny can be transmitted to a mammalian host. 
1.3. Vectors of Leishmania 
The vectors responsible for transmitting the various Leishmania parasites are female 
sand flies.  There are over 1000 species of sand fly; of this, 93 are known to spread 
leishmaniasis (Pace 2014).  Sandflies are noiseless 2-3mm long insects in colours 
ranging from black to white.  Unlike other Diptera species, their wings are 
characteristically positioned at an angle to their abdomen in a “V” shape (Killick-
Kendrick, 1999).  Female sand flies are haematophagous, and are responsible for 
disease transmission.  In the Mediterranean region they are active in the warm summer 
months (Gálvez et al. 2010), whereas in tropical regions transmission is more related to 
patterns of rainfall.  Most species of sand fly bite outdoors between dusk and dawn; 
however, there are some species that bite indoors and in the daylight.  This alternative 
behavior impacts upon the methods of insecticide spraying that are utilized to control 
them (Killick-Kendrick, 1999).  Leishmania infected sand flies can bite several times 
on the same host.  This behavior increases the chance of transmission of the parasite to 
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a new host (Ready, 2013).  Sand flies are only able to hop vertically in small distances.  
This means that sleeping higher off the floor makes an individual less likely to be bitten 
(Hewitt, 1998).  The interaction between the type of infecting species of Leishmania 
and the host’s immune response affects the expression of the disease (Alexander and 
Brombacher, 2012). 
1.4. Incidence 
The annual global incidence of leishmaniasis is over 2 million new cases (Manzano et 
al. 2011); with 0.2–0.4 million cases of visceral leishmaniasis and 0.7–1.2 million cases 
of cutaneous leishmaniasis (Manzano et al. 2014).  Sporadic or epidemic cases of 
leishmaniasis occurs when human habitation moves into an area where there is the 
sylvatic cycle of the disease (Bern et al. 2008).   
There has been an increase in serious outbreaks of visceral leishmaniasis over the last 
20-30 years in Bangladesh, Sudan, and in particular in India (Murray, 2002).  In the 
leishmaniasis endemic communities in Bihar, India, the transmission rate of 
Leishmania appears to be stable over time.  The incidence of one surveillance site 
showed rates are approximately 2.5 per 1000 people per year (Barnett et al. 2005); 
however, other areas of India show outbreaks in some communities where the incidence 
is over 10% (Kumar et al. 1999).  Patients with PKDL may maintain the infection 
between epidemics of kala-azar.  Furthermore, in highly infected areas over half the 
population may have an asymptomatic leishmanial infection.  This contributes to the 
spread of infection (Bern et al. 2007). The most recent epidemic of kala-azar in Sudan, 
lasting from 1984-1994, is estimated to have killed approximately 100,000 people 




1.5. Geographical Distribution 
Leishmaniasis is prevalent in 98 countries across the world (Alvar et al. 2012).  As seen 
in figures 1.4 and 1.5, leishmaniasis is a global disease; however, visceral leishmaniasis 
and cutaneous leishmaniasis have differences in the countries that they affect the most.  
Human leishmaniasis is found in a wide range of environments; from rain forests to 
deserts and cities; and across all continents other than Australia and Antarctica.  Despite 
the wide area in which leishmaniasis is found, the disease burden in humans is relatively 
concentrated (Bern at al. 2008).  
Visceral leishmaniasis has a disproportionate impact on countries across South Asia, 
Brazil, and the Horn of Africa, shown in figure 1.5, with 90% of all cases occurring in 
India, Nepal, Brazil, Bangladesh and Sudan (Barnett et al. 2005).  Even though the 
disease is endemic in over 60 countries, almost all of the approximately 500,000 new 
cases of symptomatic visceral leishmaniasis each year occur in the rural areas of these 
five countries.  Recurring unmanaged epidemics in India and Sudan account for the 
majority of new cases each year (Murray, 2002).  As with all leishmaniasis, visceral 
leishmaniasis predominantly affects poor and rural areas (Barnett et al. 2005).  Bihar is 
one of the poorest and most densely populated states of India, and visceral leishmaniasis 
has been endemic and epidemic there for decades (Thakur, 2000).  Cutaneous 
leishmaniasis most commonly occurs in South America, Africa, and Southwest Asia 
(Plourde et al 2012), shown in figure 1.4.  The largest focus of cutaneous leishmaniasis 
worldwide is believed to be in Kabul.  Kabul is estimated to have an incidence of 67,000 
new cases per annum (Reithinger et al. 2003).  This disease is often diagnosed in 
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military personal who have been in Southwest Asia.  Several outbreaks have occurred 
in troops who have been deployed to Iraq and Afghanistan (Plourde et al 2012). 
 
Figure 1.4 Geographical distribution of Cutaneous Leishmaniasis. Status of 
endemicity of cutaneous leishmaniasis worldwide, 2015. Source: World Health 
Organization. Leishmaniasis, Epidemiological Situation. [online] Available at: 
http://www.who.int/leishmaniasis/burden/en/ [Accessed 20 Jul. 2017). 
Mucosal leishmaniasis in South America is predominant in regions south of the 
Amazon River and is most commonly caused by Leishmania braziliensis (Lainson, 
1983); however, it is also common north of the Amazon River, in the Manaus region, 




Due to the limited resources invested into the diagnosis, treatment and control of 
leishmaniasis there is a strong association between the disease and poverty (Alvar et al. 
2006).  The main concentration of leishmaniasis is found in poor countries in South 
America, East Africa, and South East Asia; however, the disease is also endemic to 
several Mediterranean countries (Pace, 2014).  This means the parasite is of importance 
for not only the local inhabitants but also for travelers. 
 
Figure 1.5 Geographical distribution of Visceral Leishmaniasis. Status of 
endemicity of visceral leishmaniasis worldwide, 2015. Source: World Health 
Organization. Leishmaniasis, Epidemiological Situation. [online] Available at: 
http://www.who.int/leishmaniasis/burden/en/ [Accessed 20 Jul. 2017). 
Climate change as well as other environmental changes have the possibility of affecting 




1.6. Affected Population 
In Bihar, India, visceral leishmaniasis often affects older children (Thakur, 2000); 
however, in Uttar Pradesh state in India there is an equally high risk for those over the 
age of 15.  This is likely due to the fact that the disease has only recently started to 
affect Uttar Pradesh, and therefore few of the residents would have immunity, making 
children and adults equally at risk.  It was also found that the greater household 
population density the greater the protective effect.  (Barnett et al. 2005).  In Bihar, 82% 
of those affected by the disease were engaged in agriculture and animal husbandry.  
Furthermore, 78% of patients lived in close proximity to cow sheds, and 22% brought 
domestic animals into their homes at night.  The majority of the patients also lived in 
mud houses (Thakur, 2000).  
The ratio of male to females affected by leishmaniasis seems to vary.  In some areas of 
India the number of men affected can be far greater than that of women.  This could be 
because the women in these regions wear more covering clothing than the men, even at 
night, and so are less vulnerable to sand fly bites.  However, the difference in statistics 
between males and females may be due to fewer woman seeking or being sent for 
treatment due to its expense; and so are not accounted for (Thakur, 2000).  
Malnutrition, a common consequence of poverty, impairs the immunity to visceral 
leishmaniasis and so increases vulnerability to the infection (Thakur, 2000). Various 
other reasons have also led to an increase in immunosuppressed individuals.  These 
include HIV, post-transplant and chemotherapeutic patients, and biological therapies 
for chronic inflammatory conditions (Pace, 2014).  This increase in immunosuppression 




1.7. The burden of the disease 
There are several factors that need to be taken into account when assessing the burden 
of a disease.  The main aspects used to assess the disease burden are the incidence, 
prevalence, and mortality of the disease.  Other measures are important in reflecting an 
accurate account of the burden of a disease; such as the severity of the disease, disability 
that may result from it, and what quality of life patients experience due to the disease 
(Murray et al. 1996).  The measure that is most widely used when assessing the burden 
of a disease is “disability-adjusted life years lost” (DALY) (Mathers et al. 2007).   
The disease burden of leishmaniasis is thought to place leishmaniasis as having the 
second highest mortality and the fourth highest morbidity amongst all tropical diseases 
(Mathers et al. 2007).  Estimating the burden of leishmaniasis is difficult due to many 
factors; including the clinical and epidemiological diversity of the disease and the 
geographical distribution and clustering.  The lack of reliable data regarding the 
incidence, duration and impact on various disease syndromes also contributes to the 
challenge of assessing the disease burden of leishmaniasis (Bern et al. 2008).  The 
majority of the disease burden of leishmaniasis is found in poor countries; however, 
leishmaniasis is also endemic in several countries within Southern Europe (Pace 2014).  
Visceral leishmaniasis is an expensive disease to treat, and is often fatal if left untreated 
(Thakur, 2000).  In the high disease endemic villages, visceral leishmaniasis is a major 
cause of death and impoverishment (Barnett et al. 2005).  The mortality of leishmaniasis 
is second only to malaria amongst all parasitic diseases.  In terms of disability adjusted 
life years (DALYs), leishmaniasis is the third most common cause of morbidity; the 
two most common being malaria and schistosomiasis.  With leishmaniasis children 
under 15 years of age suffer most of the disease burden (Braga et al. 2013).  The impact 
of the disease on the patients and their families is not limited to its effect on health.  
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There is social and psychological stigma due to the visible and often scarring lesions 
and disfigurement (Bern et al. 2005).  The scars left by the cutaneous lesions caused by 
cutaneous leishmaniasis can have a severe social impact due to the strong stigmatization 
of those affected, especially in cases where the lesions and scars occur on the face or 
other exposed extremities (Kebede et al. 2013).  Significant economic loss is also 
common (Bern et al. 2005).  The impoverishment, disfiguration and social stigma are 
all non-health related effects of the disease which also add to the burden whilst making 
assessing it harder (Bern et al. 2008).   
The DALY estimates for leishmaniasis are based on three factors: the assumed case-
fatality rates; the assumed regional incidence and prevalence, and the disability weights 
assigned for cutaneous and visceral leishmaniasis.  However, there are many 
uncertainties for all three of these factors due to a lack of documentation for these 
assumptions.  Leishmaniasis is only considered to be a notifiable disease in 33 of the 
98 endemic countries.  Furthermore, significant underreporting of the disease is widely 
acknowledged (Desjeux, 2004); however, the magnitude of this has rarely been 
measured.  The underreporting of leishmaniasis varies between the different clinical 
presentations of the disease; between countries, even in different regions of the same 
country due to the distance from health care, the availability of treatment, and the local 
awareness of the disease (Bern et al. 2008).  Underreporting of the mortality of 
leishmaniasis is even more pronounced.  This has been shown in various studies.  One 
study in Sudan estimated that 91% of kala-azar deaths go unrecognized (Collin et al 
2006); and a study based in a village in India found that as many as 20% of visceral 
leishmaniasis patients, disproportionately women and those in poverty, died before the 
disease was recognised (Barnett et al. 2005).  Cases of mucosal leishmaniasis are 
focused in the Western Amazon, particularly south of the Amazon River.  This is where 
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L. braziliensis is the predominant species of Leishmania.  The patients with the disease 
in this area often work in areas of primary rainforest; typically involved in work related 
to the extraction of products from the rainforest.  The diagnosis of cutaneous 
leishmaniasis early in the development of disease and access to the treatment of the 
disease are crucial to avoid mucosal leishmaniasis and other complications of infection 
from developing (Guerra et al. 2011).  Often patients in these conditions do not receive 
adequate treatment and so mucosal leishmaniasis is neglected and is an important public 
health problem in the Brazilian Amazon (Lainson, 1985). Leishmaniasis is also 
considered an opportunistic disease in patients infected with HIV-1 (Santos et al. 2013). 
1.8. Symptoms 
Leishmaniasis is a disease known for its clinical diversity (Masood et al. 2012), it has 
a wide range of clinical manifestations, from self-healing cutaneous lesions to visceral 
disease (Manzano et al. 2011).  Infection may be asymptomatic or may manifest as the 
cutaneous form, which if untreated may result in disfiguring scars; or the visceral form 
of the disease which if left untreated can be lethal (Pace, 2014).  The cutaneous lesions 
that leishmaniasis causes tend to heal on their own; however, this may take from months 
to years, the healing time varying with the species of Leishmania that has infected the 
patient (Reithinger et al. 2007).  There is an increasing number of new and atypical 
clinical variants of the disease (Masood et al. 2012).   
The most common form of Leishmaniasis is cutaneous leishmaniasis.  This can be 
caused by both New and Old World species of the parasite.  Common infecting species 
that cause cutaneous leishmaniasis are Leishmania tropica and Leishmania major, Old 
World species, and Leishmania braziliensis and Leishmania mexicana, New World 
species (Reithinger et al. 2007).  The cutaneous leisions caused by the disease can vary 
in their severity, clinical manifestation, and recovery time (Kebede et al. 2013).  
18 
 
Cutaneous leishmaniasis can be localised or severe and spread across the body (Pereira 
et al. 2013); however, the cutaneous lesions which characterise the disease typically 
develop at the site of the insect bite that caused the infection (Kebede et al. 2013), as 







Figure 1.6 Cutaneous Leishmaniasis Lesion.  Cutaneous lesion on the arm caused by 
L. braziliensis. There are two subcutaneous nodules below the lesion. Source: Schwartz 
et al. 2006. 
In some cases cutaneous leishmaniasis persists and metastasizes to other areas of the 
body.  This can cause two different clinical presentations of the disease, mucosal 
leishmaniasis and diffuse cutaneous leishmaniasis (Zangger et al. 1014).  
Mucosal leishmaniasis is mainly due to the species Leishmania braziliensis (Marsden, 
1986), and is associated with inadequate treatment of cutaneous leishmaniasis (Guerra 
et al. 2011).  1-10% of leishmaniasis infections may evolve mucosal manifestations 
(Pereira et al. 2013).  It often occurs up to months or years after cutaneous leishmaniasis 
has healed.  In addition to forming after cutaneous leishmaniasis is thought to have 
healed, mucosal forms of the disease can develop from asymptomatic Leishmania 
infections (Ives et al. 2011).  The clinical features evolve slowly and commonly affect 
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the nasal cavity (Guerra et al. 2011).  Mucosal leishmaniasis starts with a single 
cutaneous lesion; however, rather than metastasising to another cutaneous region, the 
infection metastasises to mucosal tissue.  This causes chronic inflammation and 
disfiguring facial lesions (Zangger et al. 2014).  In severe cases, mucosal leishmaniasis 
can cause destruction of mucosal structures such as the nasal septum and palate, as can 
be seen in Figure 1.7.  This can lead to severe facial mutilation and, rarely, death due 
to airway involvement (Marsden, 1986).  
 
Figure 1.7 Mucosal Leishmaniasis Lesion.  A mucosal lesion with ulcerated grey-
yellow plaques on the upper palate, without perforation. Source: Schwartz et al. 2006. 
Recently, the progression of the disease to mucosal leishmaniasis has also been 
associated with infections by Leishmania guyanensis (Guerra et al. 2011).  The parasites 
genetic involvement in the control of oxidative stress potentially has a role in whether 
the disease develops metastatic complications.  Leishmaniasis is an intracellular 
infection, and so oxidative destruction is a major mechanism of parasite eradication.  
The parasites ability to avoid this method of control may be a method of developing 
latency and metastasis (Hartley et al. 2012).  Diffuse cutaneous leishmaniasis occurs 
when a cutaneous lesion metastasises to another cutaneous site.  Patients with diffuse 
cutaneous leishmaniasis are often anergic in response to the antigens of the Leishmania 
parasite and tend to respond poorly to treatment.  The mechanism by which the 
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Leishmania parasite causes these advanced pathologies of cutaneous leishmaniasis is 
unknown (Zangger et al. 2014).      
First reported in 1923 (Semon & Christopherson, 1923), Leishmaniasis recidivans, also 
known as lupoid leishmaniasis in the Old World and leishmaniasis recidiva cutis in the 
New World, is a rare form of cutaneous leishmaniasis.  Unusual clinical features and a 
chronic relapsing nature characterise leishmaniasis recidivans.  The disease is an 
evolving form of cutaneous leishmaniasis, and clinically presents with spreading of the 
original nodule.  This leads to the formation of a plaque (Masood et al. 2012), as seen 
in Figure 1.8 A.  Leishmaniasis recidivans is both clinically and histologically similar 
to lupus vulgaris, complicating the diagnosis of the disease.  The time at which 
leishmaniasis recidivans manifests after the initial cutaneous infection varies.  The 
disease presents in the same area as the scar of the old clinically healed lesion.  A 
clinical course of leishmaniasis recidivans is possibly related to changes in cell 
mediated immunity leading to localized or diffuse lesions. 
Figure 1.8 Leishmaniasis Recidivans. Source: Sharifi et al. 2010 
A: Leishmaniasis recidivans with 
active papules on the face  
B: Leishmaniasis recidivans showing a scar of 
on old cutaneous leishmaniasis lesion on the 
left and active papules on the right 
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Visceral leishmaniasis tends to be caused by Leishmania donovani and Leishmania 
infimum.  This form of the disease has several characteristic symptoms.  There is a 
progressive fever and patients suffer weight loss.  Splenomegaly and hepatomegaly are 
also seen in patients with visceral leishmaniasis, as well as hypergammaglobulinemia 
and pancytopenia (Bern et al. 2008).  Many complications may occur in visceral 
leishmaniasis.  These include immunosuppression and secondary bacterial infections, 
haemorrhaging and anaemia.   
Kala-azar is a chronic systemic form of leishmaniasis.  Its clinical characteristics are 
similar to those of visceral leishmaniasis, and eventually leads to death from bleeding 
or secondary infections (Collin et al. 2006).  If left untreated, kala-azar rapidly 
progresses and is almost always lethal (Desjeux, 1996).  Even when treated, kala-azar 
has a mortality rate of 10% or higher.  Complications including jaundice, severe 
anaemia and co-infection with HIV are all factors which can increase the risk of 
mortality (Collin et al. 2004).  If kala-azar occurs during pregnancy then foetal wastage 
and congenital leishmaniasis may also occur (Pagliano et al. 2005).  Post-kala-azar 
dermal leishmaniasis (PKDL) is a chronic rash that is found in kala-azar patients who 
were thought to be cured in South Asia and Africa (Kaushal et al. 2016).  PKDL 
presents with erythematous or sometimes hypo-pigmented macules, plaques or nodules.  
In Sudan, up to 60% of kala-azar patients develop PKDL (Zijlstra, 2006).  Data for 
South Asia is lacking, but the cumulative incidence is thought to be around 10%-20% 
(Kaushal et al. 2006).   In Sudan, PKDL has been reported to resolve itself without 
being treated in the majority of cases where the disease is mild; however, it often 
requires treatment in South Asia (Zijlstra, 2006).   
The large diversity of clinical presentations of leishmaniasis is governed by the parasite 
and host factors, as well as immuno-inflammatory responses during the course of the 
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disease (Cordeiro da Silva et al. 2009).  The variety of clinical syndromes that 
leishmaniasis can manifest with provides a challenge for diagnosis and treatment, as 
well as contributing to the burden of the disease in different ways.  The factors that 
underlie the different clinical presentations of leishmaniasis, cutaneous, visceral, and 
mucocutaneous, are unknown (Stephenson 2007).  Surprisingly, many Leishmania 
infections remain asymptomatic or sub-clinical (Murray, 2002). 
When the disease is present in patients with HIV-1 or malnutrition it can alter the 
clinical course of the disease, as well as complicating therapeutic strategies.  
Leishmaniasis in HIV infected individuals who are not severely immunosuppressed 
manifests in a similar way as in immunocompetent individuals (Alvar et al. 2008).  In 
HIV patients with CD4+ T lymphocyte counts <200 cells/µl, leishmaniasis may be 
more severe and can affect unusual sites including the gastrointestinal tract (Alvar et al. 
1997).  Without highly active antiretroviral therapy (HAART) the relapse rate after 
treatment is close to 100% (Alvar et al. 2008). 
1.9. Diagnosis 
There are various standard diagnostic procedures for cutaneous leishmaniasis.  
Microscopy or the demonstration of the parasite in culture are both used to detect the 
parasite in a skin smear or biopsy.  However, these techniques are not sensitive enough 
to confirm all cases of cutaneous leishmaniasis, even when the assays are combined 
(Kebede et al. 2013).  As systemic antibody responses are absent, serology is also 
insufficient as a diagnostic method for cutaneous leishmaniasis (Herwaldt, 1999).  
Moreover, these techniques cannot be used to distinguish between the different species 
and strains of Leishmania (Kebede et al. 2013).  
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Molecular techniques are also used to aid the diagnosis of leishmaniasis.  Molecular 
techniques that can detect the parasite-specific DNA or RNA offer advantages in the 
sensitivity of the assay and speed of detection (Wilson, 1995).  Multilocus enzyme 
electrophoresis is a classic standardised biochemical method.  It is used to distinguish 
between the different species of Leishmania.  For clinical diagnosis molecular 
techniques have recently been introduced.  These methods are especially useful when 
used in areas where different Leishmania species co-exist (Foulet et al. 2007).  These 
fast and accurate methods for the identification of the infecting parasite could facilitate 
the delivery of an appropriate treatment, adding to the attractiveness of molecular 
methods as a diagnostic strategy (Kebede et al. 2013).  The development of a rapid and 
noninvasive diagnostic technique for visceral disease has been a significant 
advancement (Murray, 2002).  The detection of anti-K39 antibodies by 
immunochromatographical strip testing can now guide clinical management accurately.  
The test only requires one drop of blood and can eliminate the need for a conventional 
diagnosis from splenic or bone marrow.  It also eliminates reliance on potentially 
inaccurate microscopy (Sundar et al. 2002).  The use of this technique may also aid in 
the detection of asymptomatic cases of leishmaniasis (Murray, 2002).   
The diagnosis for mucosal leishmaniasis is made by either using the Montenegro skin 
test, serology and histopathology of the mucosal tissue from the patient, or by the 
isolation and identification of the parasites (Guerra et al. 2001).  The best molecular 
technique that has been developed to aid the identification of the species of the infecting 
Leishmania parasite is the polymerase chain reaction (PCR) (Mimori et al. 1998), and 
is often used as a diagnostic method (Guerra et al. 2011).  However, low amounts of 
DNA in the tissue can conceal the presence of different species.  
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The diagnosis of leishmaniasis recidivans can be complicated by the paucity of the 
microorganism in the direct smear and tissue specimens (Semon, H., & Christopherson, 
J. (1923).  The clinical presentation of leishmaniasis recidivans resembles that of 
discoid lupus erythematosus (Masood et al. 2012) and lupus vulgaris, as well as some 
other gramulomatous disorders.  Due to this the differential diagnosis of the disease can 
be extremely difficult because of the similarities between their clinical features 
(Bongiorno et al. 2009).  This similarity means this is the most important differential 
diagnostic consideration. 
1.10. Treatment 
There is currently no vaccine against leishmaniasis.   Also there is no consensus 
regarding what is the best therapeutic option for the treatment of the disease.  This is 
largely due to a lack of properly controlled clinical trials (Gonzlez et al. 2008).  The 
factors that make determining the disease burden of leishmaniasis difficult also 
contribute to the difficulty in producing a large-scale intervention against the disease.  
Leishmaniasis has a very diverse geographical distribution, and while the rate of the 
disease across a region may appear to be low, focal areas can be severely affected (Bern 
et al. 2005).  Since cutaneous leishmaniasis generally heals itself, the treatment depends 
on many factors.  These include the number and site of the lesions, the aetiology of the 
disease, and personal preferences.  The main treatment used is chemotherapy (Plourde 
et al. 2012).  Treatment of leishmaniasis relies on a few first-line drugs.  These include 
miltefosine, paromomycin, and pentavalent antimonials (Manzano et al 2011). 
Leishmaniasis treatment is primarily based on pentavalent antimonials, seen in Figure 
1.9, a treatment developed over 50 years ago.  This treatment has poor therapeutic 
responses and adverse effects are common (Santos et al. 2013).  Pentavalent antimonials 
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Figure 1.9 Antimonial Treatment of Cutaneous Leishmaniasis.  The effect of 
treatment on a cutaneous lesion caused by L. braziliensis. A: Before treatment; B: At 
the end of 21 days of antimonial treatment; C: 1 month after end of treatment. Source: 
Schwartz et al. 2006 
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The main therapeutic options used for many years for the treatment of cutaneous 
leishmaniasis have relied on local or systemic administration of pentavalent antimony 
(Wortmann et al. 2002).  Since Leishmania parasites are susceptible to heat, radio 
frequencies can be applied at the sites of the lesions to generate heat.  This has also 
shown to yield a cure rate similar to systemic pentavalent antimony.  In addition to the 
treatments currently available, effective oral treatments would benefit treatment of 
cutaneous leishmaniasis (Plourde et al. 2012).  As previous treatments required 
injections over periods as long as four weeks (Murray, 2001) the establishment of 
effective oral treatments is of great importance (Murray, 2002).  There is evidence of 
the benefit of the use of oral triazoles, such as itraconazole and fluconazole, in treating 
against L. tropica and L. major, respectively (Gonzlez et al. 2008).  Another orally 
administered drug that has shown to be effective is miltefosine.  It was shown to be 
effective in treating against cutaneous leishmaniasis in South America (Soto et al. 
2004), and visceral leishmaniasis in India (Sundar, Jha et al. 2002); however, there is 
limited data about its efficacy against cutaneous leishmaniasis in Southwest Asia 
(Plourde et al. 2012).  The introduction of new oral treatments in India should be of 
great benefit as around half of all leishmaniasis cases occur there and drug resistance 
has rendered treatment by pentavalent antimony largely useless (Murray, 2001).  
The only treatment currently available for leishmaniasis is chemotherapy; however, its 
efficacy is increasingly limited due to the growing drug resistance to first-line drugs; 
especially antimonials (Manzano et al. 2014).  One mechanism by which Leishmania 
is resistant to antimony involves a reduction in its accumulation.  This is either by 
reduced uptake or increased efflux; the latter being mediated by ABC transporters 
(Brochu et al. 2003).  ABC transporters are one of the largest families of proteins and 
are involved in a broad range of physiological roles which have major medical 
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consequences (Ouellette et al. 2004).  ABC proteins are evolutionarily highly conserved 
and are found in difference species, ranging from prokaryotes to humans.  These 
proteins use energy from adenosine triphosphate (ATP) hydrolysis to transport different 
compounds.  This includes transporting a variety agents used to treat leishmaniasis; 
including antimonials and miltefosine, across biological membranes (Manzano et al. 
2014). 
Due to the limited number of active drugs for leishmaniasis the World Health 
Organisation (WHO) recommended combination therapy to extend the life expectancy 
of these compounds.  As part of the search for cheaper oral treatments for visceral 
leishmaniasis new drugs, such as the 8-aminoquinolines, are being developed.  The 
development of antiprotozoal drugs has used the 8-aminoquinoline scaffold 
extensively; generally as antiplasmodial compounds.  Recently, sitamaquine and 
tafenoquine have been used as alternative leishmanicidal compounds.  The introduction 
of these drugs is at differing stages due to differences in their haematological toxicity 
(Manzano, 2011).  Tafenoquine is an 8-aminoquine analogue of primaquine.  It is used 
in clinical trials for the treatment and prevention of Plasmodium infections (Walsh et 
al. 2004), and is a potential candidate for alternative leishmaniasis therapy.  The drug 
has shown strong leishmanicidal activity in vitro.  It affects the mitochondrial activity 
in the Leishmania parasites, which leads to an apoptosis-like death process (Carvalho 
et al. 2010). 
In patients with HIV-1, highly active antiretroviral therapy (HAART) is used as a 
treatment and has shown a strong reduction in opportunistic infections; this includes 
opportunistic infections caused by parasites (Pozio and Morales, 2005).  Despite this, 
patients that are coinfected with HIV and visceral leishmaniasis could be a reservoir for 
the development and spread of drug-resistant strains of Leishmania (Van Griensven 
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and Boelaert, 2011).  Patients who do not receive HAART have a higher chance of 
developing the pathology of leishmaniasis.  Furthermore, acquired immune deficiency 
syndrome (AIDS) treatment shows an increased risk of failure.  Multiple anti-HIV 
drugs are used in HAART; including aspartic peptidase inhibitors (PIs).  Aspartic 
peptidases are also found in the Trypanosomatidae family.  Soluble extracts of 
Leishmania amazonensis have been shown to be capable of degrading synthetic 
substrates that are designed for aspartic peptidases.  This degradation is eliminated by 
selective aspartic peptidase inhibitors (Santos et al. 2013). 
The HIV PIs nelfinavir and loppinavir are aspartic peptidase inhibitors that have been 
shown to cause major alterations in several crucial points of the life cycle of L. 
amazonensis. These stages include proliferation, invasion of macrophages, 
ultrastructural aberrations and the expression of virulence factors (Santos et al. 2009).  
Other species of Leishmania have also shown to be effected by HIV PIs; including 
Leishmania major, Leishmania mexicana, Leishmania braziliensis, Leishmania 
donovani, and Leishmania infantum.  There is not full agreement regarding the 
susceptibility of distinct species of Leishmania to HIV PIs.  There are inconsistencies 
between reports, and it is still unknown if they are due to different methodologies, what 
kind of strains and species are assayed, and the drug origin (Santos et al. 2013). 
1.11. Management and prevention 
The eradication of leishmaniasis depends of satisfactory and easily available treatment 
and effective preventative measures (Murray, 2002).  There are several control methods 
that are currently being deployed.  These include the spraying of houses with residual 
insecticides and the culling of dogs.  The early detection and treatment of infections is 
also of great importance in the management of leishmaniasis, including the detection 
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of PKDL (Guerin et al. 2002).  In addition to these measures, newer procedures such as 
insecticide-impregnated bed nets and dog collars have shown promising effects 
(Murray, 2002). 
A study into kala-azar in areas of south Sudan has found that only half of patients with 
kala-azar had access to treatment.  Due to the absence of roads and vehicles the patients 
often have to reach health care on foot or be carried on stretchers, on journeys that often 
last several days.  Many of the patients would be too unwell to make the journey and 
may die whilst attempting to travel to the treatment centers.  Furthermore, access to 
treatment is further limited by the rainy season, impassable rivers, and sometimes by 
tribal or military conflicts (Collin et al. 2006).  An epidemiological study of visceral 
leishmaniasis in the Indian state Uttar Pradesh found that the disease was commonly 
thought to be restricted to Bihar, and of little concern to Uttar Pradesh.  Some villages 
knew of the disease, but in others few people had heard of kala-azar, its cause, and the 
symptoms it presents with.  The doctors in the area knew little about visceral 
leishmaniasis and very rarely considered it in their differential diagnosis.  Due to this, 
many cases of the disease often go unrecognized and untreated.  With visceral 
leishmaniasis becoming an increasing danger in Uttar Pradesh management of disease 
needs to improve (Barnett et al. 2005). 
The lack of development into a vaccine for leishmaniasis is largely due to the low 
investment into this neglected parasitic disease.  Insight has been provided by research 
from the UK, Brazil and France into the genes involved in causing different forms of 
leishmaniasis, potentially aiding in the development of drugs and vaccines (Peacock et 
al. 2007).  The high number of asymptomatic cases of leishmaniasis affects the 
management of the disease.  What causes the disease to remain asymptomatic or 
subclinical indicates that the host-parasite relationship may favour the host (Murray, 
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2002).  Investigation into the circumstances that lead to this could help with the 
development of a vaccine (Handman, 2001). The particular species of Leishmania that 
has infected the patient, and its resistance patterns, affects the efficacy of the treatment.  
The main preventative measures are aimed at avoiding sand fly bites.  This is effective 
in reducing the contraction of leishmaniasis.  Vector control measures are primarily 
based on insecticide-treated nets and indoor residual spraying (Killick-Kendrick, 1999).  
This is thought to greatly reduce the incidence of leishmaniasis (Bern et al. 2008).  
These measures need to be promoted to travelers who are visiting endemic regions.  
During the intensive DDT spraying for malaria in the 1950s and 1960s, the reported 
incidence of visceral leishmaniasis reduced to zero; however, a resurgence of the 
disease predominantly in northeastern Bihar occurred in the 1970s, with an explosive 
epidemic in the early 1990s (Barnett et al. 2005).  A case study in Nepal found that, in 
addition to the use of nets arounds beds, the presence of cattle or buffalo helps protect 
against transmission of the Leishmania parasite; and that damp earthen floors was a risk 
factor (Bern et al. 2000).  A study based in communities of Bangladesh identified that 
the availability of bed nets, even untreated ones, was a strong protective factor against 
the disease; and that proximity to a previous case of visceral leishmaniasis was the 
strongest indicator of risk of contracting the disease (Bern et al. 2005).  In contrast to 
the studies in Nepal and Bangladesh, the study in Uttar Pradesh found little significant 
protective effect from the bed nets or mosquito coils.  This could be due to only a few 
of the villagers using bed nets and statistical limitations of the study.  Moreover, many 
people slept outside during the summer making the nets harder to use and the coils less 
effective (Barnett et al. 2005).  A study in Bangladesh also found that an increase in the 
presence of cattle correlated with a lower human incidence rate (Bern et al. 2005).  In 
contrast, a study in Sudan found that the presence of cattle increased the risk of 
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transmission (Bucheton et al. 2002) as did the Uttar Pradesh study.  Cattle presence is 
likely to increase risk of leishmaniasis transmission, as the cattle manure is a preferred 
food source and habitat for sand fly larvae, and so its presence leads to an increased 
sand fly density (Dinesh et al. 2001).  A possible explanation for the differing effects 
of cattle presence on infection rate could be sleeping habits.  In the Bangladesh study 
community, less than 5% of the study participants slept outdoors; in contrast with 77% 
in participants in the study in Uttar Pradesh (Barnett et al. 2005). 
In theory it is evident what needs to be done to control leishmaniasis.  The rate of 
transmission needs to be reduced by vector control and the control of infected 
reservoirs.  Resistance in the susceptible population needs to be induced via a vaccine.  
Many hopes are resting on the development of a vaccine as most transmission control 
efforts have been unsuccessful, unstable, or too expensive (Murray, 2002).  If an 
effective and affordable vaccine were to be developed it could have a great impact on 
leishmaniasis.  It could mean the successful immunization of animals (Handman, 2001) 
and increased resistance to the disease in humans (Murray, 2001).  The identification 
of the infecting parasite species by genetic analysis can contribute to the understanding 
of leishmaniasis (Guerra et al. 2011).  Poverty greatly increases the risk of 
leishmaniasis, and therefore anti-poverty and housing improvement programs could be 
implemented as part of a long term control strategy for the disease (Thakur, 2000). 
Leishmaniasis is increasing in the Northern Hemisphere.  This is a result of tourism and 
armed conflicts in tropical regions (Amato et al. 2008). 
1.12. Aims of the Study 
The aims of this study are to examine the relationship between the Leishmania parasite 
species Leishmania tropica and Leishmania aethiopica.  These species are thought to 
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be closely related and have a geographical overlap.  In this study, PCR for the ITS1 
sequence was applied to isolates of both species, and compared to results of the RPL23a 
sequence.  Observing DNA sequences of the two species could help establish the 
phylogenetic distance between them.  The other aim of this study was to investigate the 
presence of the Leishmania Ribonucleic Acid (RNA) Virus (LRV) in L. tropica and L. 
aethiopica.  The LRV has previously been found in some isolates of L. aethiopica, but 
has not been found in L. tropica.  The presence of the virus has been linked to metastatic 
developments in leishmaniasis, and so identification of its presence could aid diagnosis 
and appropriate treatment of the disease.  Whether LRV is found in L. tropica could 
contribute to knowledge about the differences between L. tropica and L. aethiopica, 
and so has potential to improve diagnosis, treatment, and management of clinical 
infections.  The presence of LRV was investigated using a double stranded (ds) RNA 




Chapter Two: Literature Review 
2.1. Leishmania tropica and Leishmania aethiopica 
There are at least 20 different species of Leishmania that are known to infect humans 
(Stephenson, 2007).  Although host factors play an undeniable role in the course of 
leishmaniasis, parasite pedigree is the most reliable predictive tool of disease 
phenotype; which implies that heritable factors of the parasite are the most significant 
determinants of clinical variation of the disease (Hartley et al. 2012).  The identification 
of the parasite is best done by using polymerase chain reaction (PCR)-based methods 
(Guerra et al. 2011).  The species Leishmania aethiopica and Leishmania tropica are 
cutaneous leishmaniasis causing species of Leishmania.  L. tropica and L. aethiopica 
appear to be related species; although their phylogenetic inter-relationship is only 
partially understood.  Geographically, L. aethiopica is restricted to Ethiopia and Kenya; 
whereas L. tropica is more widely dispersed, ranging from the Eastern Mediterranean, 
through the Middle East into eastern India and in north, east and south Africa (Krayter 
et al. 2015).  The predominant animal reservoirs in Ethiopia of L. aethiopica are the 
hyrax species Procavia capensis and Heterohyrax brucei (Ashford et al. 1973), and the 
giant pouch rat Cricetomys sp. is suspected to be a reservoir for L. aethiopica in addition 
to hyraxes (Alvar et al. 2012).  P. capensis has also been found to be a reservoir for L. 
tropica in Israel (Svobodova et al. 2006) and Namibia (Grove, 1989).  Leishmaniasis is 
a major health concern in South America, and a wide spectrum of the disease 
pathologies are present across the country.  The infecting species of Leishmania affects 






Figure 2.1 The geographical distribution of Leishmania species in the Old World 
including L. tropica and L. aethiopica in 1994. Source: Colour Atlas of Tropical 
Dermatology and Venerology 
L. tropica is a causative agent of cutaneous leishmaniasis.  For a long time L. tropica 
was mistaken for L. major and there was only one proven vector.  In recent years more 
research has been made into the parasite (Jacobson, 2013).  Different species of 
Leishmania can be found in the same region.  Figure 2.1 shows a map of the 
geographical distribution of several Old World Leishmania species, including L. 
tropica and L. aethiopica.  The map is from 1994 and is somewhat outdated.  It shows 
no presence of L. tropica in Africa, where it has since been found; however, accurate 
distribution maps are difficult to obtain as the surveillance of the disease varies on a 
county by country basis.  A map based on verified cases may not be an accurate 
representation of the disease.  Before identification of species was easily and routinely 
done by molecular methods, the identification of clinical isolates was presumed based 
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on the species known to be present in the region or in similar habitats.  Typing of clinical 
isolates was rarely done, and only occurred in larger institutions, and identification 
performed in the field would often be based on expectations.  Improved surveillance 
and increased access to molecular tools are needed to produce a more accurate map of 
species distribution.     
Leishmania major is the main cause of cutaneous leishmaniasis in Iraq; however, L. 
major and L. tropica have both been found to cause the disease in Afghanistan.  
Differences between the clinical features have been found between the species.  The 
most apparent of these is that L. tropica tends to cause more chronic infections and may 
cause a progression of the disease to viscerotropic leishmaniasis, the systemic form of 
the disease.  This requires special attention (Plourde et al. 2012).  Typically, a specific 
species of Leishmania either has anthroponotic transmission or zoonotic transmission; 
however, L. tropica may be transmitted zoonotically although it predominantly has an 
anthroponotic cycle (Pace, 2014).  Strains of L. tropica have displayed considerably 
serological, biochemical, molecular biological and genetic diversity.  Cutaneous 
leishmaniasis caused by L. tropica is a public health threat in Morocco (Krayter et al. 
2014).  There are three species that cause human cutaneous leishmaniasis in Morocco, 
L. major, L. infantum, and L. tropica.  Of these species, L. tropica is the most widely 
spread geographically (Rhajaoui et al. 2007).  Cutaneous leishmaniasis caused by L. 
tropica infections has been increasing in Morocco, leading to it being considered a 
major public health hazard since 1997 (Alvar et al. 2012).  There have also been isolated 
cases of canine cutaneous leishmaniasis and canine visceral leishmaniasis caused by L. 
tropica reported in Morocco (Krayter et al. 2014). 
Cutaneous leishmaniasis is the main presentation of Leishmania infection in Ethiopia 
(Zangger et al. 2014).  The incidence of cutaneous leishmaniasis in Ethiopia is 
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suggested to range from 20,000 to 50,000; however there is no accurate figure for the 
burden of the disease in the country (Alvar et al. 2012).  Recently, there has been an 
increase in the reported number of cases of cutaneous leishmaniasis in Ethiopia (Negera 
et al. 2008).  Leishmaniasis occurs in both rural and urban areas of Ethiopia (Kebede et 
al. 2013).  The prevalence of the disease varies with location within the country, mostly 
being sporadic or endemic (Zangger et al. 2014).  Four species of Leishmania are known 
to be the causative agents of cutaneous leishmaniasis in Ethiopia: L. major, L. tropica, 
L. aethiopica, and occasionally L. donovani, which causes visceral leishmaniasis more 
often (Krayter et al. 2015).  L. aethiopica is considered to be the predominant etiological 
agent of cutaneous leishmaniasis in Ethiopia (Kebede et al. 2013).  In addition to 
localised cutaneous leishmaniasis, L. aethiopica also causes mucosal leishmaniasis and 
diffuse cutaneous leishmaniasis (Ashford et al. 1973).  Of these species of Leishmania 
that cause cutaneous leishmaniasis in Ethiopia, L. aethiopica is the only species that is 
restricted to Africa.  This geographical restriction could be due to the restricted 
geographical range of its main sand fly vector species, Phlebotomus longipes and 
Phlebotomus pedifer (Alvar et al. 2012).  L. aethiopica is one of the Leishmania 
parasites that causes cutaneous leishmaniasis and subsequently the mucosal and diffuse 
cutaneous forms of the disease (Zangger et al. 2014).  The increasing cases of 
leishmaniasis in Ethiopia and the diverse clinical manifestations occurring there 
highlight the epidemiological significance of the disease in the country (Kebede et al. 
2013).  In Kenya, L. aethiopica has only been reported to cause localised cutaneous 
leishmaniasis (Alvar et al. 2012).   
The L. aethiopica species was originally identified as L. tropica when it was first 
isolated from cases of localised and diffuse cutaneous leishmaniasis in humans.  These 
strains were later described and named a new species, L. aethiopica, due to the various 
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criteria.  Factors that were involved in the reclassification as a new species include the 
geographical restriction of human cases; the association between some of the strains 
and diffuse cutaneous leishmaniasis, previously only known to be caused by New 
World species; the specificity of the sand fly vectors and hyraxes being the animal 
reservoir hosts, and the antigenic specificity of the strains (Krayter et al. 2015).  
Serotyping using indirect haemagglutination was used to show the antigenic specificity 
of the strains (Bray et al. 1973), and was later corroborated by excreted factor (EF) 
serotyping (Schnur and Zuckerman, 1977).  Over the last 30-40 years many strains of 
L. aethiopica from Kenya and Ethiopia have been serotyped according to the excreted 
factor that they produce.  The results of this has shown all of the strains examined were 
found to be a EF sub-serotype that has so far been exclusive to the L. aethiopica species 
of Leishmania, the EF sub-serotype B1.  This has antigenically separated the strains 
from all other species of Leishmania (Krayter et al. 2015). 
A close relationship between L. aethiopica, L. tropica and L. major has been suggested 
by phylogenetic studies on different cellular components of the parasites (Krayter et al. 
2015).  A close relationship between L. aethiopica and L. tropica was indicated by 
studies based on electrophoretic motilities of enzymes (MLEE) comparing enzyme 
profiles of various strains of Leishmania (Le Blancq et al. 1986).  However, MLEE 
studies on the mobility profiles of other enzymes showed a closer relationship with L. 
major, with L. aethiopica and L. major forming a monophyletic group (Pratlong et al. 
2009). 
Analysis of the length of polymorphisms of microsatellite-containing regions has 
recently become an important method for studying populations and genetics of different 
species of Leishmania (Tóth et al. 2000).  Microsatellites are tandemly repeated short 
stretches of nucleotide motifs.  They are typically one to six base pairs long, and are 
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ubiquitously distributed throughout the genomes of eukaryotic organisms.  The rate of 
mutation for microsatellites is five to six orders of magnitude higher than the mutation 
rate of the bulk DNA.  The microsatellite loci present high variability, largely due to 
allelic repeat length variations (Kebede et al. 2013).  Screening for the length variation 
of individual loci is easily done after amplification with PCR primers that anneal 
specifically to their flanking regions (Sampaio et al. 2003).  Leishmania parasites are 
relatively rich in microsatellites (Rossi et al. 1994).  The short sequences are dispersed 
throughout the genomes of the parasites, and are highly polymorphic and codominant 
(Kebede et al. 2013).  Microsatellite loci of the Trypanosomatidae family have been 
shown to be stable under laboratory conditions, and are detectable directly in biological 
samples even when there is a low amount of the parasite DNA (Macedo et al. 2001).  
Moreover, the results from microsatellite analysis are easy to store in databases and 
compare between laboratories (Ochsenreither et al. 2006). 
The use of multilocus microsatellite typing (MLMT) has proven to be a useful method 
for identifying different strains of Leishmania.  MLMT has an advantage over other 
methods for identification and characterization as it is reproducible and can be 
transferred between laboratories (Schönian et al. 2011).  It has been found to be a useful 
method for the study of population genetics and epidemiological investigations of 
different Leishmania species (Bulle et al. 2002).  MLMT has been used to reveal 
geographical and hierarchic population structures for L. major, L tropica and the L. 
donovani complex (Schönian et al. 2011).   
There are sixteen microsatellite markers that have been designed for L. tropica 
(Schwenkenbecher et al. 2004).  MLMT of L. tropica has shown it to have extensive 
genetic variation.  The application of MLMT to strains of L. tropica found in Morocco 
showed that species separated into two genetically distinct clusters (Schwenkenbecher 
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et al. 2006).  Strains of the parasite tended to cluster to their geographic origin.  Possible 
explanations to explain the genetic diversity existing in a single focus include: the 
introduction of separate and distinct genetic species from different regions to a 
previously unaffected area; mutations occurring in a single original species that are 
associated with genetic exchange; and recent hybridisation and recombination resulting 
in distinctly separate progenies (Krayter et al. 2014), as has been reported for L. 
infantum (Rogers et al. 2014).  Mutations alone are unlikely to account for the distinct 
separation of L. tropica strains found in certain areas.  Although genetic clustering of 
parasite strains most often associates to the geographic region, this is not always the 
case.  This could be due to individuals being infected while in another country, but 
being diagnosed as a local case when they return to their home country.  The application 
of MLMT to L. tropica found in Morocco revealed the parasites separating into two 
separate groups, each primarily associated with a particular geographical focus but with 
strains from each population occasionally found in the population of the other focus.  
This indicates that the genetic clustering of the parasites is not exclusively due to 
geographical or temporal factors (Krayter et al. 2014).     
The close relationship between L. tropica and L. aethiopica was confirmed by the 
successful application of the 12 microsatellite markers to strains of L. aethiopica; the 
markers were originally thought to species specific to L. tropica.  The Bayesian and 
distance based methods of analysis showed strains of L. aethiopica to be clustered 
amongst the African strains of L. tropica; whereas factorial correspondence analysis 
showed the two species to be clearly separated (Krayter et al. 2015). 
It is thought that there are only a few species-specific genes that are important in 
determining which form of leishmaniasis develops from the infection.  This is from a 
study where the genomes of three species of Leishmania that cause different forms of 
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the disease were compared.  The study found that the species differed in only 200 of 
the >8000 genes in the genome.  This indicates that these few genes are responsible for 
determining the differences in the form of the disease that develops or that the parasite 
genome only has a small involvement in the clinical presentation of the disease 
(Stephenson, 2007). Common factors to all Leishmania species may potentially be used 
as drug targets or candidates for vaccines (Stephenson 2007). 
2.2. Use of DNA Sequences for Identification and Phylogenetics of Leishmania 
The detection and identification of parasitic species is often central for studies into the 
understanding of many factors of the parasite; including the biology, immunology, 
pathology, and epidemiology.  This knowledge underpins the instigation and 
implementation of measures to control against diseases that afflict many people with 
social and economic consequences (Snounou, 1996).  Microscopy can be used to detect 
the presence of a parasite, and in some cases can identify the species of a parasite.  
Microscopy has many advantages, mainly its relatively low cost and its availability for 
most field conditions; however, alternative methods are required for high sensitivity of 
detection and accurate identification (Snounou, 1996).  These higher levels of 
sensitivity and accuracy can be obtained through the detection of parasite nucleic acids 
(Barker, 1990).  The need and use of molecular biological techniques has culminated 
in the use of the polymerase chain reaction (PCR) (Saiki et al. 1998). 
A method used for classification an organism does not necessarily mean it can be used 
for the identification of the organism, and vice versa.  The level of phylogenetic 
classification used has a differing role in identification.  Classification on the level of 
evolutionary comparisons would not work for identification of different species.  The 
DNA sequence used needs to be of a resolution appropriate for the level of identification 
and classification required.  A homologous gene, or homolog, is a gene that is inherited 
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in two species from a common ancestor.  Homologous genes can be orthologs or 
paralogs.  An orthologous gene is one that has diverged after a speciation event, but the 
gene and main function is conserved.  When a gene duplicates within a species, the 
resulting duplicate genes are paralogs of each other; even though they might 
differentiate in sequence and function over time. When used for either identification or 
classification it is important that orthologues are compared. 
PCR is potentially the most sensitive method for specific detection of a particular DNA 
sequence in a sample.  This is because in theory successful amplification only needs 
one copy of the DNA sequence to be present.  The only limitation of the PCR method 
is in the amount of the sample that can be screened (Snounou, 1996).  PCR can be used 
for identification and classification of a species of a parasite by targeting different DNA 
sequences; and the sequence of DNA amplified is dependent on the primers used.  
Microsatellites provide an insight into the genetics of the parasite on a very small scale.  
These can be used to observe the phylogenetic pattern of different parasite isolates 
within a single species; however, they are often species-specific and so cannot be used 
to compare the relationships between different species.  On the other hand, ribosomal 
RNA can be used to study phylogeny on a broad, evolutionary scale, and so would not 
be able to identify different species of the same parasite.  The target sequence for PCR 
depends on the scale of phylogeny and identification that is desired.   
Leishmania parasite isolates can be identified by sequencing the PCR product generated 
by using ITS1 specific primers; and performing sequence alignments against the 
Leishmania genome database.  Species-specific primers could provide a quicker, cost 
effective, and highly useful tool for typing and diagnosis of L. aethiopica.  This could 
aid case detection and the determination of the appropriate therapeutic measures to take, 
in addition to the implementation of control measures.  Furthermore, a restriction 
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enzyme digestion step is not required for this method as is needed in restriction 
fragment length polymorphism (RFLP), and so it provides an added advantage in 
accelerating species identification (Kebede et al. 2013).  Although this would aid in the 
identification of L. aethiopica, it would not be able to identify different species, and 
would not provide insight into the relationship between L. aethiopica and other species.   
2.3. Leishmania RNA Virus 
An RNA virus was detected to be present in some South American species of 
Leishmania parasites several decades ago; however, the role of the virus in the virulence 
and metastasis of leishmanial infections was only described recently.  The nucleic acid 
of LRV1 acts as a potent innate immunogen in some species of Leishmania parasites.  
The resulting inflammatory cascade increases disease severity, parasite persistence, and 
possibly anti-leishmanial drug resistance.  LRV1 has mainly been found in clinical 
parasite isolates that are prone to infectious metastasis development; this has been found 
in both human cases and animal models.  LRV1 presence in infections prone to 
metastasis development suggests that there is an association between the viral pathogen 
and metastatic complications of the disease, such as mucocutaneous leishmaniasis 
(Hartley et al. 2012).    
Infection with some species of Leishmania including L. braziliensis, L. guyanensis and 
L. aethiopica have shown inflammatory metastatic forms of leishmaniasis, causing not 
only cutaneous leishmaniasis but mucosal leishmaniasis and disseminated 
leishmaniasis also.  There is a lack of knowledge as to the factors that underlie this 
exacerbated clinical presentation (Zangger et al. 2014).  Over ten different species of 
Leishmania parasite cause leishmaniasis in South America (Reithinger et al. 2007), with 
seven different species causing cutaneous leishmaniasis in humans (Guerra et al. 2011).  
Leishmania braziliensis and Leishmania guyanensis are the two primary etiological 
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agents of the disease in Brazil. (Pereira et al. 2013).  Mucosal leishmaniasis and other 
metastatic complications of Leishmania infections such as diffuse cutaneous 
leishmaniasis also occur in other parts of the world other than South America, such as 
Ethiopia (Zangger at al. 2014).  Metastatic complications can occur and mucosal 
leishmaniasis can develop even in formally asymptomatic leishmaniasis infections 
(Hartley et al. 2012).  Mucosal leishmaniasis primarily affects the nasal cavity, as well 
as other mucosal structures, and can cause perforation or destruction of the septum.  L. 
braziliensis is recognised as the most important etiological agent for mucosal 
leishmaniasis in the New World; however there are isolated cases of the disease being 
caused by several different species such as Leishmania panamensis, Leishmania 
amazonensis, and L. guyanensis in the Amazon region.  Previously it was thought that 
L. guyanensis infection causing mucosal leishmaniasis was very rare; however, this 
could be due to limited studies in areas where L. guyanensis is endemic (Guerra et al. 
2011).  The genetic variability of the infecting Leishmania parasite does not account 
for all of the variability in the clinical presentation of the disease (Schonian et al. 2000). 
The range of outcomes is illustrated in Figure 2.2. 
The progression of leishmaniasis to other forms of the disease appears to be due to 
many aspects of the infection (Reithinger et al. 2007); with the presentation of the 
disease likely reflecting the polygenetic factors of the host and parasite (Zangger et al. 
2014).  One of these factors is the parasite’s resistance to oxidative stress (Acestor et al 
2006).  In addition to the parasite features, host factors such as the age and gender of 
the patient, as well as their nutritional and immune status (Reithinger et al. 2007), and 
a range of genetic susceptibilities are able to affect the progression of the disease 
(Sakthianandeswaren et al. 2009).  The clinical variation in the manifestation of a 
Leishmania infection appears to be largely influenced by the parasite pedigree; however 
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unique genes between species of the parasite are relatively scarce (Smith et al. 2007).  
There are some species-specific genes between the genomes of L. major, L. mexicana, 
L. infantum and L. braziliensis; however, the pattern from these differences is not 
sufficient to explain the symptomatic grouping (Rogers et al. 2011).   
 
Figure 2.2 Leishmanial phylogeny and LRV presence. Intrinsic parasite factors for 
some species of Leishmania that underlie clinical disparities in metastatic 
leishmaniasis. Source: Hartley et al. 2012. 
 LRV found in numerous isolates within group 
 LRV found only in a single, perhaps exceptional, isolate in this group 
CL, Cutaneous leishmaniasis; DCL, Disseminated cutaneous leishmaniasis; VL, 
Visceral leishmaniasis; PKDL, Post Kala Azar dermal leishmaniasis; MCL, 
Mucocutaneous leishmaniasis; LRV, Leishmania RNA virus 
 
Although previously believed that infection with certain species of Leishmania would 
only lead to the development of specific presentations of the disease, it is now known 
that several factors influence the various clinical development of leishmaniasis.  Figure 
2.2 shows the clinical disease that is most often found with infections by each species.  
Mucosal leishmaniasis is almost exclusively caused by infections of the L. (Viannia) 
subtype of Leishmania.  This is a further indication that leishmanial metastasis is caused 
in part by a component of the parasite.  The presence of LRV in the parasites of this 
subgenus potentially contributes to the destructive inflammation of the metastatic form 
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of the disease.  This could be by either acting alongside other metastatic factors or by 
preying on the host’s toll like receptor (TLR) hypersensitivity (Hartley et al. 2012).  The 
presence of LRV may prove to be a driving factor of metastatic potential in L. (Viannia) 
parasite infections (Ronet et al. 2011).  Mucocutaneous leishmaniasis development is 
associated with a persistent pro-inflammatory immune response; and so the immune 
status of the patient appears to influence the development of the disease (Blackwell, 
1999).  The onset of a destructive hyper-inflammatory immune response is a common 
occurrence in most cases of metastatic Leishmania infections.  It is characterized by a 
flooding of activated immune cells, swelling, and the destruction of the local tissue 
(Ronet et al. 2011).  The hyper-inflammatory immune response common to mucosal 
leishmaniasis infections may be instigated by a parasite factor (Hartley et al. 2012).  
Furthermore, co-infection with HIV also increases the risk of mucosal leishmaniasis 
(Alvar et al. 2008).  Recently, the presence of LRV in the infecting parasite has been 
associated with the progression of the disease to mucosal leishmaniasis (Guerra et al. 
2011), where in L. guyanensis mouse infections it was reported that inflammation and 
the severity of the infection was associated with a high burden of the virus infecting the 
parasites; suggesting that the LRV presence could be contributing to the severity of the 
disease in metastasizing leishmaniasis (Ives et al. 2011). 
The Leishmania RNA virus (LRV) is a symbiotic component of the Leishmania 
parasites found in South America (Pereira et al. 2013).  LRV has mainly been found in 
South America in the Leishmania species L. braziliensis and L. guyanensis (Zangger et 
al. 2014).  The Leishmania RNA virus is a member of the Totiviridae family.  Other 
viruses that affect protozoa and fungi are also members of this family.  LRV is a double 
stranded RNA virus that has been found to persistently infect different Leishmania 
lineages.  LRV has been categorised into LRV1 and LRV2 (Pereira et al. 2013).  LRV2 
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has been identified in the Old World species Leishmania major (Scheffter et al. 1995).  
LRV1 has also been found in some strains of L. braziliensis and L. guyanensis.  These 
strains of Leishmania circulate in specific areas of South America (Saiz et al. 2011).   
The viral particles are comprised of a capsid protein; an RNA-dependent RNA 
polymerase (RdRp), and a segmented double stranded RNA genome 5.3kb in length 
(Zangger et al. 2014).  Like many Totivridae viruses LRV1 is neither infectious nor 
shed, and so it is viewed as a long term, evolutionary endosymbiont.  The effects of the 
virus on the mammalian host arise indirectly via the parasite rather than through direct 
infection of the mammalian host by the virus (Hartley et al. 2014).  LRV was first 
described over two decades ago (Stuart et al. 1992); however it has only recently been 
reported to have an influence on the development of mucosal leishmaniasis.   
As LRV presence may be one of the factors determining the severity of the disease in 
leishmaniasis it provides reason to screen different species of Leishmania for the 
presence of the virus.  There have been instances where LRV has been reported outside 
of South America, also infecting other Leishmania species such as in certain L. 
aethiopica strains in Africa and a L. major strain in central Asia.  This could indicate 
that LRV was present before the divergence of the Leishmania subgenera.  Sequencing 
of the LRV found in the L. aethiopica parasites, LRV-Lae, and the LRV2 found in L. 
major has shown that these viruses are members of the same Totiviridae family as the 
LRV1 viruses that were found in South America (Zangger et al. 2014).   
High loads of LRV1 in the infecting parasite have been associated with parasite 
persistence, metastasis, and evasion of the host immune response.  The recognition of 
LRV1 within metastasizing Leishmania parasites by the host promotes inflammation 
and subverts the immune response against the parasite infection, leading to the 
persistence of the parasitic infection (Ives et al. 2011).  In a mouse model of L. 
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guyanensis infection the presence of the Leishmania RNA virus has been shown to be 
responsible for a hyper-inflammatory response.  The mice infected with LRV1-bearing 
strains of L. guyanensis exhibited higher levels of parasites in the blood and greater 
footpad swelling (Ives et al. 2011).  This was driven by the host’s Toll-like Receptor 3 
(TLR3) recognizing the viral RNA, leading to an exacerbation of the disease.  When 
TLR3 recognizes the viral RNA it induces pro-inflammatory cytokines and 
chemokines.  These are hallmarks of human mucosal leishmaniasis (Zangger et al. 
2014).  The recognition of LRV1 by the host occurs early on in the Leishmania 
infection; this suggests that the LRV1 dsRNA is released from dead parasites which 
were unable to survive within the macrophage of the host (Ives et al. 2011).  
Furthermore, a study infecting macrophages in vitro with LRV1 positive L. guyanensis 
(Ives et al. 2011) and LRV2 positive L. aethiopica (Zangger et al. 2014) showed a 
higher release of cytokines, phenotypes that were dependent on TLR3.  The 
investigation of several strains of Leishmania parasites is needed to fully determine if 
the presence of the virus favours the development of mucocutaneous leishmaniasis and 
increases the rate of disease relapse (Scott 2011).  Metastasis does occur in the absence 
of LRV; however, LRV1 mediated hyper-inflammatory immune responses could 
explain the differences between the clinical outcomes observed in different species and 
strains of Leishmania (Pereira et al. 2013).  
Studies have also shown that LRV1 presence in L. braziliensis (Adaui et al. 2016) and 
L. guyanensis (Bourreau et al. 2016) clinical isolates correlates with drug treatment 
failure. The immunological hallmarks of a mucocutaneous infection of leishmaniasis 
are similar to those of the reaction to LRV.  These include the production of type 1 
interferons; impairment of the host cells ability to eliminate parasites via oxidative 
stress, and a bias towards a chronic Th1 inflammatory state (Hartley et al. 2012).   
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LRV1 presence in leishmaniasis has been investigated using a nested retro-transcription 
polymerase chain reaction in Brazil.  In the areas of Rio de Janeiro that are endemic for 
leishmaniasis there was no LRV1 detected, even with mucosal involvement.  LRV1 has 
been detected in cutaneous legions caused by Leishmania guyanensis in the northern 
region.  These samples were obtained from patients who were presenting with disease 
reactivation after receiving clinical treatment for their primary legions.  In areas of Rio 
de Janeiro where severe leishmaniasis is primarily caused by Leishmania braziliensis 
there is no association with Leishmania LRV1 infection (Pereira et al. 2013).   
Although there are many parasite and host factors affecting the development of mucosal 
leishmaniasis, it appears that LRV1 has a role in exacerbating the pathogenesis of the 
disease.  Investigation into the role of LRV in the development of mucosal 
leishmaniasis could lead to improved diagnosis of the risk of disease development; and 
aid the development of new and improved treatments (Ives et al. 2011).  Since LRV 
presence amplifies the virulence of Leishmania infections its presence potentially 
provides a unique target for diagnosis and clinical intervention of mucosal 
leishmaniasis (Hartley et al. 2012).  Some species of Leishmania have been found to 
express a potent RNA-mediated interference (RNAi) activity (Lye et al. 2010).  The 
parasitic genes that control RNAi are of interest as it is a possibility that this defense 
mechanism recognises the nucleic acid of LRV1 and targets the foreign RNA (Hartley 
et al. 2012).  In the RNAi pathway, double stranded RNA is converted into small 
interfering RNAs (siRNAs).  SiRNA then triggers the degradation of a messenger RNA 
(mRNA) with a complementary sequence (Wilson and Doudna, 2013).  Functional 
RNAi is not present in most of the L. Leishmania subgenera, but can be found in major 
metastatic leishmaniasis causing parasites of the L. Viannia group, including L. 
braziliensis and L. guyanensis (Lye et al. 2010) where LRV1 has been found to be 
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present.  Active RNAi often controls RNA viruses in many organisms; however, LRV1 
has been found to survive in its presence (Brettmann et al. 2016). Further investigation 
into the possibility that the retention or loss of RNAi in Leishmania parasites is related 
to an evolution of the viral interaction (Hartley et al. 2012).  It is also possible that 





Chapter Three: Materials and Methods 
 
3.1. Laboratory Work 
3.1.1 The Parasites 
Materials 
The Leishmania parasites used in this study were provided by the Lancaster University 
Cryo-Bank.  The parasite isolates used are listed in Table 3.1. 25 isolates of Leishmania 
parasites were used in this study, a mixture of L. tropica and L. aethiopica, as shown in 
Table 3.1.  An isolate of L. major (MRHO/SU/1959/LV39) and of L. guyanensis 
(MHOM/BR/1975/M4147) were also used as controls. 
Table 3.1 Table of parasite isolates used with WHO code, country of origin, and source 







MHOM/ET/XX/L86 Ethiopia Human CL 
LV13 L. 
aethiopica 
MHOM/ET/70/L96 Ethiopia Human CL 
LV15 L. 
aethiopica 
MPRV/ET/70/L97 Ethiopia Rock hyrax 
LV25 L. 
aethiopica 
MPRV/ET/71/L111 Ethiopia Rock hyrax 
LV26 L. 
aethiopica 












MHOM/ET/72/L127 Ethiopia Human CL 
LV377 L. 
aethiopica 










Ethiopia Human DCL 
LV697 L. 
aethiopica 
XXXX/ET/XX/5.104 Ethiopia Unknown 
LV142 L. tropica MHOM/IQ/65/LRC-L32 Iraq Human LR 
LV357 L. tropica MHOM/SU/60/LRC-L39 USSR Human CL 
LV369 L. tropica MHOM/SA/68/11 Saudi Arabia Human CL 
LV444 L. tropica MHOM/NA/71/VS Namibia Human CL 
LV487 L. tropica IROS/NA/71/RossiI Namibia Phlebotomus 
rossi 
LV488 L. tropica IROS/NA/71/RossiII Namibia Phlebotomus 
rossi 
LV489 L. tropica IROS/NA/71/RossiIIIa Namibia Phlebotomus 
rossi 
LV490 L. tropica IROS/NA/71/RossiIIIb Namibia Phlebotomus 
rossi 
LV508 L. tropica MHOM/IQ/XX/IN Iraq Human CL 
LV509 L. tropica MHOM/IQ/XX/NA Iraq Human CL 
LV510 L. tropica MHOM/IQ/XX/SA Iraq Human CL 
SU23 L. tropica MHOM/TR/98/SU23 Tunisia Human CL 





The following materials were used for in vitro culture of Leishmania promastigotes: 
BioWhittaker® Medium 199 from Lonza; Dulbecco’s Phosphate Buffered Saline from 
SIGMA; BME vitamins from SIGMA; Foetal Bovine Serum from Thermo-Fisher, and 
Gentamicin (10mg/ml) from PAA – The Cell Culture Company. 
The culture medium for the Leishmania parasites (M199 complete) was prepared as 
follows. To 500ml of M199 base medium 10% Foetal Bovine Serum (FBS) was added, 
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5ml BME vitamins, and 1.2ml of gentamicin solution.  The mixture was filter sterilised 
by passage through a 0.2µ filter unit under vacuum suction, and stored at 4°C.  
The parasites were cultured in 10ml volumes of M199 complete culture medium using 
25 cm2 tissue culture flasks and incubated at 26󠅨°C. The parasite cultures were regularly 
checked by microscopy and passaged at 1:20 dilution approximately once per week. 
For harvesting 7-10ml volumes were placed into sterile polypropylene capped test tubes 
and centrifuged at 1500g for 10 minutes; after which the supernatant was discarded.  
The parasite pellet was resuspended in 2ml Phosphate-buffered saline (PBS) and then 
two 1ml aliquots placed into microfuge tubes, centrifuged at 10,000g and the 
supernatant discarded.  The pellets were snap-frozen and stored at -80°C until required 
for DNA extraction. 
3.1.3 Preparation of Leishmania DNA for PCR 
Materials 
The following materials were used to prepare DNA: QIAGEN DNeasy® Blood and 
Tissue Kit Cat. No. 69504; Phosphate Buffered Saline from SIGMA. 
The Leishmania pellets were directly resuspended in 200µl PBS after removal from -
80°C and stored on ice.  The DNA of the Leishmania was prepared using the DNeasy 
kit.  20µl proteinase K and 4µl RNAse A were added to the resuspended pellet and 
incubated for 2 minutes at room temperature.  200µl of AL buffer was then added, 
mixed by vortexing, and incubated at 56°C for 10 minutes.  200µl of 100% ethanol was 
then added and mixed into the sample.  The mixture was carefully transferred to the 
surface of a spin column and centrifuged at 8000g for 1 minute, under which conditions 
the DNA binds to the column matrix.  The flow through was discarded and 500µl AW1 
buffer added to wash the bound DNA.  The spin column was again centrifuged at 8000g 
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for 1 minute and the flow-through was discarded.  500µl AW2 buffer was added to the 
spin column and centrifuged at 14000g for 3 minutes for a second wash.  The spin 
column was then transferred to a microfuge tube and 100µl AE buffer added for DNA 
elution.  After incubating at room temperate for 1 minute or longer, the column was 
centrifuged at 8000g for 1 minute.  The amount of DNA recovered was measured using 
a NanoDrop Spectrophotometer. 
3.1.4 Polymerase Chain Reaction 
Materials 
DNA polymerase and the PCR buffer 5X from the QIAGEN HotStar HiFidelity 
Polymerase Kit were used in this method. 
DNA amplification was done by Polymerase Chain Reaction (PCR).  The main target 
of the PCR was ribosomal RNA ITS-1 sequence; however, the RPL23a IGS was also 
used in some of the early experiments.  The primers used for ITS-1 were LEF and LER, 
and the primers used for RPL23a IGS were PS1 and PS2 (Table 3.2). 
Primers Sequences 
LEF 5' TCC GCC GCA AAG TTC ACC GAT A 3' 
LER 5' CCA AGT CAT CCA TCG CGA CAC G 3' 
P1 5' GCG CCA ACA AGA CTG AGA T 3' 
P2 5' CGT CAC CTT GAC GAC CTT G 3' 
Table 3.2. Primer names and sequences for PCR amplification. 
For PCR 10µM dilutions of the primers were prepared.  The final volume to be used in 
the PCR was 25µl, this was composed of molecular grade dH2O; 5µl HotStar HiFidelity 
PCR Buffer 5X; 1µl of Primer 1 (LEF/PS1); 1µl of Primer 2 (LER/PS2); 0.5µl HotStar 
HiFidelity DNA polymerase, and the DNA to be tested.  100ng/µl of DNA was used, 
and depending on the volume of DNA used the volume of water was adjusted to make 
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up the 25µl final volume.  The most common volumes used were 2µl DNA and 15.5µl 
molecular grade dH2O. 
After the reaction mix was prepared accordingly in a PCR-grade tube, the ingredients 
were gently mixed and briefly spun in a microfuge.  The tubes were then placed in the 
















72°C for 10 
minutes 
4°C 57 30 
72 60 
Table 3.3. PCR Cycling Parameters 
3.1.5 Agarose Gel Electrophoresis 
Materials 
The following materials were used in this method: molecular biology grade agarose 
from SIGMA;  TAE 1X buffer was made from TAE 50X buffer from QIAGEN; 6X 
DNA loading dye from Thermo Scientific, and GelRed Nucleic Acid Stain from 
Biotium. 
The agarose gel was made by mixing and heating 1.5% agarose (0.75g) in 50ml TAE 
1X buffer.  After cooling slightly the agarose was poured into the gel mould and left to 
polymerise for around 30 minutes with a loading comb in place.  Once set, the comb 
was removed and the gel was placed in a gel tank with TAE 1X buffer filling the tank 
and just covering the gel.  5µl of the 100bp DNA ladder was loaded on the gel.  2µl 
DNA from the PCR was mixed on parafilm with 1µl 6X loading dye and 3µl dH2O and 
was loaded.  The gel was run at 90V for approximately 40 mins.  After this the gel was 
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stained with GelRed for 30 minutes whilst being agitated.  The gel was imaged on a 
BioRad Chemidoc system. 
3.1.6 PCR Purification 
Materials 
All materials needed for this method except the microfuge tubes came from the GeneJet 
PCR Purification Kit from Thermo Scientific. 
The GeneJet PCR Purification Kit was used to purify the PCR products.  A 1:1 volume 
(25µl) of Binding Buffer was added to the PCR mixture.  For the ITS-1 PCR products 
an equal volume (25µl) of isopropanol was also added since the ITS-1 DNA fragment 
is ≤500bp. This was transferred to a GeneJet purification column. All centrifugations 
were carried out at 10,000g for 60 seconds.  The supernatant was discarded and 700µl 
of Wash Buffer was added to the column.  This was centrifuged; the supernatant 
discarded, and centrifuged again.  The column was then transferred to a new microfuge 
tube and 50µl of Elution Buffer was added and left for at least 1 minute.  The column 
was then centrifuged again and the microfuge tube kept.  The DNA concentration was 
measured on the NanoDrop.  Another agarose gel was also run, and a sample checked 
to ensure that a clean product had been produced. 
3.1.7 Preparation of Samples for Sequencing 
Sequencing of the PCR samples was done externally by Source Bioscience. 
Each reaction requires 5µl of sample, but 20µl was prepared to allow for repeats.  1ng/µl 
per 100 bp of DNA was required.  The ITS-1 product is 400bp and the RPL23a IGS 
product is 698bp.  This meant 80ng/µl DNA was required for the ITS-1 PCR products 
and 139.6ng/µl DNA required for the RPL23a IGS PCR products.  The volume of DNA 
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needed to produce the needed amount of DNA was calculated using the ng/µl value 
from the NanoDrop spectrophotometer. 
5µl of each primer was also needed per reaction, at a concentration of 3.2pmol/µl.  
10nmol/l primers were used, and the required concentration made by mixing 10µl of 
primer stock and 21.25µl dH2O. 
3.1.8 Dot Blot 
Materials 
The following materials were used in this method: nitrocellulose membrane from the 
BIO-RAD Trans-Blot® Turbo™ RTA Transfer Kit; PBS was from SIGMA; dried 
skimmed milk used was from TESCO; to make the TBS: Tris from ALDRICH, sodium 
chloride from Fisher Scientific, and hydrochloric acid from SIGMA-ALDRICH were 
used; to make the TBS-T Tween®20 from SIGMA was used; anti-Mouse IgG HPR 
conjugate antibody from PROMEGA, and ECL reagent from BIO-RAD Clarity™ 
Western ECL Substrate; the J2 anti-dsRNA antibody was from SCICONS. 
The preparation of the parasites for the dot blot started with the parasite pellets from 
the −80°C freezer.  The pellet was resuspended in cold PBS to reach a dilution of 
3.125x108 cell equivalents/ml and kept on ice.  A 2.5 fold dilution was prepared by 
taking 10µl of this first dilution and diluting it by mixing with 15µl PBS.  A second 
dilution was prepared from this the same way. The resulting concentrations were the 
equivalent of 3.125x108/ml, 1.25x108/ml, and 5x107/ml.  2µl spots were used in the 
experiment, and therefore each contained 6.25x105, 2.5 x105, and 1 x105 promastigote 
equivalents, respectively.  When not being used the lysate samples were kept at −80°C. 
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The blot was performed using a nitrocellulose membrane.  The nitrocellulose was 
handled wearing gloves and using forceps.  A grid was drawn outlining where different 
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Figure 3.1. Dot blot nitrocellulose membrane layout 
The membrane was left to air dry. Once the membrane was dried it was soaked for 60 
minutes in 5% powdered milk in 20ml TBS-T to block non-specific sites. Next the 
membrane was incubated for 30 minutes with the antibody J2 (mouse-anti-dsRNA).  
The J2 antibody was prepared at a 1:3000 dilution with 20ml TBS-T.  The membrane 
was then washed in TBS-T four times, 5 minutes each.  Next the membrane was 
incubated with the rabbit anti-mouse-conjugated secondary antibody for 30 minutes.  
The secondary antibody was in a 1:2000 dilution with 1% milk TBS-T.  The membrane 
was then washed in TBS-T again; first for 15 minutes, then for 5 minutes two times.  
The final wash was 5 minutes in TBS.  All washes and incubations were on a rocker. 
The membrane was incubated in 2mls ECL reagent for 1 minute.  Excess solution was 
removed from the surface by covering the membrane in cling film.  Within 10 minutes 
the membrane was read on the Chemidoc.  The main exposure time used was 8 seconds. 
The membrane was post-stained with Ponceau red to detect the total protein present.  
This was left incubating for 30-60 minutes on a rocker. The membrane was rinsed with 
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dH2O and read on the Chemidoc. When testing the different Leishmania parasites for 
the presence of the viral RNA a positive and negative control was used each time.  The 
positive control was L. guyanensis M4147 and the negative control was L. major LV39. 
 
3.2. Data Analysis 
3.2.1 Processing PCR Sequencing Results 
Materials 
Forward and reverse sequences were obtained for each PCR product sequenced. These 
were initially checked using Chromas Lite 2.6.4 (Technelysium Pty Ltd) for suitable 
quality – good peak separation and base calling with minimal ambiguity. The reverse 
complement of the reverse sequences was found using the Bioinformatic website, 
which should match to the forward sequence.  The forward sequence and the 
reverse/reverse complement were compared using the DNA version of Clustal Omega 
from the European Bioinformatics Institute website. If the two sequences were the 
same, they were combined to generate a consensus DNA sequence for the particular 
parasite sample. Finally the DNA sequence was identified to be either L. tropica or L. 
aethiopica using the nucleotide BLAST programme on the National Centre for 
Biotechnology Information website by searching for similar sequences already 
discovered. 
Worked example  
























































CLUSTAL O(1.2.1) multiple sequence alignment by the DNA and RNA Clustal 
Omega from the European Bioinformatics Institute website 
RC      GCGCCAANCAGANTGAGATCAAGAAGGCAATGCGCAAGCTGTACCAGGTGAAGGCCGTGA 
F       ------------------------------------------------------------ 
 
RC      AGGTCAACACCCTGATCCGTCCGGATGGTCTGAAGAAGGCGTACATCCGCCTGTCTGCGG 
F       ---------------TCCGTCCGGATGGTCTGAAGAAGGCGTACATCCGCCTGTCTGCGG 
                       ********************************************* 
RC      CCCACGATGCTCTGGACACTGCCAACAAGATCGGTCTTGTCTAAGCAGAATTTGGATGAT 
F       CCCACGATGCTCTGGACACTGCCAACAAGATCGGTCTTGTCTAAGCAGAATTTGGATGAT 
        ************************************************************ 
RC      GCGATTACTTGAGATAATTTCATTTTATCAACAACGAAAAAGAAGTGCTACGGTAACTTT 
F       GCGATTACTTGAGATAATTTCATTTTATCAACAACGAAAAAGAAGTGCTACGGTAACTTT 
        ************************************************************ 
RC      GGTGCACCAGAGGCTGGCGACGGCTCTTAGGGTGGTTTAATGAGGTGTTACCTCTATGGT 
F       GGTGCACCAGAGGCTGGCGACGGCTCTTAGGGTGGTTTAATGAGGTGTTACCTCTATGGT 
        ************************************************************ 
RC      AAACTGAAGTGATCAGCTGCGGTATCTTTGTGCGCGTCGAGGGTGCGCTGGTTTCTGCAT 
F       AAACTGAAGTGATCAGCTGCGGTATCTTTGTGCGCGTCGAGGGTGCGCTGGTTTCTGCAT 
        ************************************************************ 
RC      CTCCGAGTTTGTGATTCTCTCTGAAGATGTATTGCAAAAAGTGCGCTGCGGCGCTGCTTT 
F       CTCCGAGTTTGTGATTCTCTCTGAAGATGTATTGCAAAAAGTGCGCTGCGGCGCTGCTTT 
        ************************************************************ 
RC      TCTACTCCTGCGCTGCTGTTCCTTCAAATGTGTCGACATGTCCGACTTTCTGCAGCTGCT 
F       TCTACTCCTGCGCTGCTGTTCCTTCAAATGTGTCGACATGTCCGACTTTCTGCAGCTGCT 
        ************************************************************ 
RC      CACCTCCACTTTCATCTCTCCCTCTTCCTTTTTTTTTCTGTGTGTCCATGCGTCTCGTGT 
F       CACCTCCACTTTCATCTCTCCCTCTTCCTTTTTTTTTCTGTGTGTCCATGCGTCTCGTGT 
        ************************************************************ 
RC      GCGTCTCAACTTGCGACAACTTTTCTTGCGCCCTTCTGTGGAATACCATCTGAACAGCTT 
F       GCGTCTCAACTTGCGACAACTTTTCTTGCGCCCTTCTGTGGAATACCATCTGAACAGCTT 
        ************************************************************ 
RC      TAGGGCTTCANTCGCAACGGATCGNGCCNCCNNTCNGAAGACC----------------- 
F       TAGGGCTTCATTCGCAACGGATCATGCCTCCTGCTCAGAAGACCGCCAAGAAGGCCGCGC 
        ********** ************  *** **       *   *                  
RC      -------------------------------------- 
F       CAAAGGATGCGAAGGCGACCAAGGNCNNNNNGGTGACG 
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Consensus = 459 nt 
Identification from National Centre for Biotechnology Information website  
99% identical to L. major FV1  
 
3.2.2. Phylogenetic Trees  
Materials 
The phylogenetic trees were generated using the Molecular Evolutionary Genetics 
Analysis (MEGA) software.  The L. donovani and L. infantum ITS1 sequences were 
found using the nucleotide BLAST on the National Centre for Biotechnology 
Information website.  The sequences were aligned using the DNA Clustal Omega 
programme from the European Bioinformatics Institute website. 
The ITS1 DNA sequences from the PCR were aligned using L. major, L. donovani, and 
L. infantum as different outgroups, and entered into the MEGA software.  Using the 
software the best model of sequence evolution was determined to be Jukes-Cantor, and 
a Maximum Likelihood Tree was generated with bootstrap method of 500 replications.  





3.2.3. Distance Pairwise Analysis 
Materials 
The distance pairwise data was generated using the MEGA software.  The sequences 
were aligned using the DNA and RNA Clustal Omega from the European 
Bioinformatics Institute website. 
The ITS1 DNA sequences were aligned and entered into the MEGA software.  Pairwise 
Distance using the sequences was generated in MEGA with the Nucleotide 
Substitutions in a p-distance model.  This was done for the comparison of L. tropica 
and L. aethiopica data, and for a L. tropica and L. major comparison, and a L. donovani 





Chapter Four: Results 
 
4.1. DNA Sequencing 
4.1.1 Polymerase Chain Reaction 
There were two main aims to this study and these provided two separate sets of results.  
The first stage of the study was to compare the ITS1 DNA sequences of various L. 
tropica and L. aethiopica parasite isolates produced using the polymerase chain 
reaction (PCR). Two control isolates were used, one L. major and one L. guyanensis, 
to develop the experimental method and which are known to be distinct from the closely 
related L. tropica and L. aethiopica parasite isolates.  These isolates were also to be 
used as controls in the viral RNA dot blot experiments.  Another sequence was also 
examined, the RPL23a intergenic sequence (between two tandemly repeated RPL23a 
genes), for the first four parasite isolates to be examined.  These provided further 
technical controls, and also acted to demonstrate reproducibility, as they were compared 
to the RPL23a sequences generated in previous work.  
The parasites were cultured in vitro as promastigotes, pellets produced, DNA extracted 
and then PCR reactions performed, using the P1 and P2 primers for the RPL23a 
sequence and the LEF and LER primers for the ITS1 sequence.  Agarose gel 
electrophoresis was performed to check the PCR products, such as the example shown 
in Figure 4.1.  If this indicated suitable quality (clear band of the expected size: ~400 
bp for ITS-1; ~700 bp for RPL23a) the product was adjusted to the correct concentration 
and sent for sequencing by Source Bioscience. The resulting sequences were analysed 
and used to generate a consensus sequence for each isolate as described in Materials 
and Methods. Full sequence data are recorded in Appendix I. In some cases the 
sequencing was successful at the first attempt. However, some required additional 
attempts to resolve poor amplification or ambiguity in the sequence data. For three 
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isolates amplification was successful but clear sequence data could not be obtained for 
ITS-1 (LV142, SU23 and LV29). Table 4.1 shows a summary for each of the 23 isolates 
examined. This includes their original species identification based on criteria such as 
geographical origin, their identification by RPL23a sequence data, and their 












Figure 4.1 Agarose Gel Electrophoresis for RPL23a and ITS1 PCR products from L. 
major LV39 and L. guyanensis M4147. Products were examined on a 1.5% agarose gel 
and visualized with Gel Red. Products of the correct size were obtained as illustrated 
and their identity confirmed by sequencing and BLAST searching. 
The results for the L. tropica and L. aethiopica parasite isolates tested show a number 
of interesting features.  With one exception (LV28) there is correspondence between 
the two molecular identification methods, which gives some confidence in their use. 
For LV28, subsequent to this work being done the ITS-1 and RPL23a PCRs were 


























ITS1 product (400nt) 
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confirmed the L. tropica result for ITS-1 but indicated a mixed sequence for RPL23a. 
The results also show that three Leishmania isolates that were originally identified as 
L. aethiopica (LV697, LV13 and LV1), when tested were found to actually be L. tropica 
for both the RPL23a and ITS1 sequences. PCRs for the RPL23a sequence for LV357, 
LV25 and LV456 were repeated in this study, in addition to PCR for the RPL23a 
product for LV39 and M4147, and confirmed earlier results.   
Isolate Original ID RPL23a ID ITS1 ID 
    
LV357 L. tropica L. tropica (457) L. tropica (308) 
LV508 L. tropica L. tropica (457) L. tropica (308) 
LV697 L. aethiopica L. tropica (458) L. tropica (313) 
LV142 L. tropica L. tropica (457) - 
SU23 L. tropica L. tropica (458) - 
LV13 L. aethiopica L. tropica (457) L. tropica (313) 
LV1 L. aethiopica L. tropica (459) L. tropica (306) 
LV369 L. tropica L. tropica (458) L. tropica (308) 
LV509 L. tropica L. tropica (458) L. tropica (308) 
LV487 L. tropica L. tropica (457) L. tropica (308) 
LV444 L. tropica L. tropica (457) L. tropica (308) 
LV489 L. tropica L. tropica (457) L. tropica (308) 
LV488 L. tropica L. tropica (457) L. tropica (308) 
LV490 L. tropica L. tropica (457) L. tropica (308) 
    
LV27 L. aethiopica L. aethiopica (460) L. aethiopica (324) 
LV377 L. aethiopica L. aethiopica (460) L. aethiopica (327) 
LV546 L. aethiopica L. aethiopica (460) L. aethiopica (326) 
LV29 L. aethiopica L. aethiopica (460) - 
LV472 L. aethiopica L. aethiopica (460) L. aethiopica (325) 
LV28 L. aethiopica L. aethiopica (460) L. tropica (308) 
LV26 L. aethiopica L. aethiopica (460) L. aethiopica (327) 
LV15 L. aethiopica L. aethiopica (460) L. aethiopica (330) 
LV25 L. aethiopica L. aethiopica (460) L. aethiopica (327) 
 
Table 4.1: Table showing the original identification, the RPL23a PCR identification, 
and the ITS1 identification performed in this study for 23 L. tropica and L. aethiopica 
parasite isolates. The results in bold are from this study; the remainder were from a 





4.1.2. Phylogeny  
Maximum likelihood phylogenetic trees were generated with the MEGA program using 
the ITS1 sequences generated by PCR, which are recorded in Appendix I. Figure 4.2 
shows a phylogenetic tree produced using a Jukes-Cantor with Gamma distribution 
model of sequence evolution, selected by the software as the best fitting model from 
those available. The outgroup used in Figure 4.2 was the sequence from the L. major 
LV39 isolate used in this study.  Both L. donovani and L. infantum were also tested as 
alternative outgroups and gave essentially identical results, which are shown in 
Appendix III, but the L. major outgroup provided a tree with higher bootstrapping 
values.  The phylogenetic tree in Figure 4.2 shows a single strong branch point with 
99% bootstrap value separating all of the parasite isolates identified as L. aethiopica in 
this study.  There is a more complex branching among the rest of the isolates within the 
L. tropica group.  LV28, the isolate that was identified as L. aethiopica originally and 
with the RPL23a sequence but as L. tropica with the ITS1 sequence is amongst the L. 
tropica isolates. 
Phylogenetic trees were also generated using RPL23a sequences previously found for 
L. tropica and L. aethiopica, recorded in Appendix II, as shown in Figure 4.3.  The 
outgroup used in Figure 4.3 was L. major, and L. donovani and L. infantum were also 
tried as outgroups, see Appendix III.  As with the ITS-1 sequence dataset all three 
produced similar trees but the bootstrapping was higher on the L. tropica outgroup.  
Again there is a strong branch point separating the isolates identified as L. tropica and 
L. aethiopica with the RPL23a sequence.  There is branching within both the L. tropica 
and L. aethiopica groups, but the branching is more extensive within the L. tropica 
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isolates.  However, these branch points are different than the branch points amongst the 
L. tropica isolates in Figure 4.2.  
 
 
Figure 4.2: Phylogenetic tree of ITS 1 sequences for L. tropica and L. aethiopica with 





L. aethiopica group 
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Figure 4.3: Phylogenetic tree of RPL23a sequences for L. tropica and L. aethiopica 
with L. major as an outgroup. The scale represents 0.02 amino acid substitutions per 
site. 
 
4.1.3. Distance Pairwise 
In order to explore the differences between and within the L. aethiopica and L. tropica 
groups in more detail, pairwise comparisons were made between all the sequences to 
determine their percentage identity. In these analyses 100% identity is indicated by a 
pairwise distance of 0.0, the value rising as the sequences become more dissimilar. For 
comparison Table 4.2 shows the Distance Pairwise Comparison for ITS1 sequences of 
Leishmania species L. infantum and L. donovani, and L. tropica and L. major.  L. 
tropica and L. major are known to be different species from both molecular and 
L. aethiopica group 
69 
 
biological characteristics, whereas the position of L. infantum and L. donovani is less 
clear but with most researchers regarding them as very closely related species.  Table 
4.3 shows a Distance Pairwise Comparison for all the L. tropica and L. aethiopica 
isolates ITS1 DNA sequences anaylsed in this study. The distance pairwise results for 
L. tropica isolates against other L. tropica isolates can be seen to produce mostly low 
values; lower than both distance pairwise results for the Leishmania species pairs in 
Table 4.2.  The distance results for LV508 and 509 do not fit this however.  The distance 
results for these two L. tropica isolates are higher when compared to the other L. tropica 
parasites, and are higher than the result for L. infantum and L. donovani in Table 4.2.  
However, the distance result when comparing LV508 and LV509 to each other is very 
low. Table 4.3 shows that the L. aethiopica isolates compared to other L. aethiopica 
isolates have low distance values, lower than both the distance pairwise values for the 
Leishmania pairs in Table 4.2.  The only exception for this is LV28, which has higher 
distance values against the other L. aethiopica isolates, and low values when compared 
to the L. tropica isolates.  The distance values in Table 4.3 for the L. aethiopica isolates 
apart from LV28 compared against the L. tropica isolates are higher than against the 
other L. aethiopica parasites.  The difference value is higher than that of L. infantum 
and L. donovani in Table 4.2; however they are still lower than the distance value for 





L. infantum  
L. donovani 0.059 
L. tropica LV357  
L. major 0.192 
Table 4.2. Distance Pairwise Comparison for L. tropica and L. major, and L. donovani 
and L. infantum ITS1 Sequences
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Table 4.3. Distance Pairwise Comparison for L. tropica and L. aethiopica isolates ITS1 Sequences 
  
  L. tropica with L. tropica 
  L. aethiopica with L. aethiopica 
  L. tropica with L. aethiopica  








 LV1 LV13 LV357 LV369 LV444 LV487 LV488 LV489 LV490 LV508 LV509 LV697 LV15 LV25 LV26 LV27 LV28 LV377 LV472 
LV1                    
LV13 0.036                   
LV357 0.032 0.032                  
LV369 0.047 0.047 0.014                 
LV444 0.022 0.036 0.040 0.054                
LV487 0.022 0.036 0.040 0.054 0.000               
LV488 0.022 0.036 0.040 0.054 0.000 0.000              
LV489 0.022 0.036 0.040 0.054 0.000 0.000 0.000             
LV490 0.022 0.036 0.040 0.054 0.000 0.000 0.000 0.000            
LV508 0.137 0.137 0.112 0.126 0.137 0.137 0.137 0.137 0.137           
LV509 0.151 0.147 0.126 0.140 0.147 0.147 0.147 0.147 0.147 0.072          










LV15 0.119 0.115 0.101 0.115 0.112 0.112 0.112 0.112 0.112 0.176 0.176 0.112        
LV25 0.122 0.119 0.104 0.119 0.115 0.115 0.115 0.115 0.115 0.180 0.180 0.115 0.004       
LV26 0.122 0.119 0.104 0.119 0.115 0.115 0.115 0.115 0.115 0.180 0.180 0.115 0.004 0.000      
LV27 0.133 0.129 0.115 0.129 0.126 0.126 0.126 0.126 0.126 0.180 0.180 0.126 0.032 0.032 0.032     
LV28 0.004 0.032 0.029 0.043 0.018 0.018 0.018 0.018 0.018 0.133 0.147 0.043 0.115 0.119 0.119 0.129    
LV377 0.122 0.119 0.104 0.119 0.115 0.115 0.115 0.115 0.115 0.180 0.180 0.115 0.004 0.000 0.000 0.032 0.119   
LV472 0.126 0.122 0.108 0.122 0.122 0.122 0.122 0.122 0.122 0.183 0.183 0.119 0.011 0.007 0.007 0.040 0.122 0.007  
LV546 0.126 0.122 0.108 0.122 0.122 0.122 0.122 0.122 0.122 0.183 0.183 0.119 0.011 0.007 0.007 0.040 0.122 0.007 0.000 
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An alternative way of displaying this data is shown in Figure 4.4.  This shows the values 
for the Distance Pairwise Comparison of L. tropica and L. aethiopica isolate ITS1 
sequences to the L. tropica isolate LV1.  Figure 4.4 illustrates the grouping of most of 
the L. tropica isolates together and below the threshold for L. donovani and L. infantum, 
with the exception of LV508 and LV509 as noted above. The L. aethiopica isolates are 
grouped together and clearly distinct from the L. tropica group, with the exception of 
LV28. 
 
Figure 4.4. Graph of Pairwise Distance for ITS1 L. tropica and L. aethiopica Isolates 
against LV1 (L. tropica) with Pairwise Distance for L. infantum and L. donovani, and 

























Leishmania Parasite Isolate ID
L. donovani and L. infantum
L. tropica and L. major
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Similar analyses were performed for the RPL23a dataset. Table 4.4 shows the Distance 
Pairwise Comparison for the RPL23a sequences of L. infantum and L. donovani, and L. 
tropica and L. major and Table 4.5 shows this for the L. tropica and L. aethiopica 
isolate.   
In Table 4.5, the distance pairwise results for L. tropica isolates against other L. tropica 
isolates can be seen to be mostly low values.  All the values are lower than both distance 
pairwise results for the Leishmania species pairs in Table 4.4, with the exception of 
LV13 and LV697.  The distance results for the LV13 and LV697 L. tropica isolates are 
higher when compared to the other L. tropica parasites, and are higher than the result 
for L. infantum and L. donovani in Table 4.4.  When comparing LV13 and LV697 to 
each other the distance pairwise has a very low value.  The distance results for these 
isolates compared to the L. aethiopica isolates are higher than when they were 
compared to the L. tropica isolates.    
The distance values in Table 4.5 for the L. aethiopica isolates compared against the L. 
tropica isolates are higher than when comparing like against like, and higher than that 
of L. infantum and L. donovani in Table 4.4; however, they are still lower than the 
distance value for L. tropica and L. major.  LV13 and LV697 have the highest 
difference values out of the L. tropica isolates when being compared against the L. 
aethiopica parasites. 
Table 4.5 shows that L. aethiopica isolates compared to other L. aethiopica isolates 
have low distance values, lower than both the distance pairwise values for the 
Leishmania pairs in Table 4.4. All of the results from the distance pairwise comparison 
in Table 4.5, including those for LV13 and LV697, are lower than the distance pairwise 







L. infantum  
L. donovani 0.006 
L. tropica LV357  
L. major 0.050 
Table 4.4. Distance Pairwise Comparison for L. tropica and L. major, and L. donovani 
and L. infantum RPL23a Sequences 
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Table 4.5. Distance Pairwise Comparison L. tropica and L. aethiopica isolates RPL23a Sequences 








 LV1 LV13 SU23 LV142 LV357 LV369 LV697 LV508 LV510 LV15 LV25 LV26 LV27 LV28 LV29 LV377 LV472 
LV1                  
LV13 0.019                 
SU23 0.004 0.023                
LV142 0.002 0.017 0.006               
LV357 0.002 0.017 0.006 0.000              
LV369 0.004 0.023 0.000 0.006 0.006             
LV697 0.027 0.008 0.023 0.025 0.025 0.023            
LV508 0.002 0.017 0.006 0.000 0.000 0.006 0.025           










LV15 0.029 0.042 0.029 0.027 0.027 0.029 0.046 0.027 0.027         
LV25 0.027 0.040 0.027 0.025 0.025 0.027 0.044 0.025 0.025 0.002        
LV26 0.027 0.040 0.027 0.025 0.025 0.027 0.044 0.025 0.025 0.002 0.000       
LV27 0.023 0.038 0.023 0.021 0.021 0.023 0.042 0.021 0.021 0.006 0.004 0.004      
LV28 0.027 0.040 0.027 0.025 0.025 0.027 0.044 0.025 0.025 0.006 0.004 0.004 0.004     
LV29 0.025 0.040 0.025 0.023 0.023 0.025 0.044 0.023 0.023 0.008 0.006 0.006 0.002 0.006    
LV377 0.023 0.038 0.023 0.021 0.021 0.023 0.042 0.021 0.021 0.006 0.004 0.004 0.000 0.004 0.002   
LV472 0.025 0.040 0.025 0.023 0.023 0.025 0.044 0.023 0.023 0.008 0.006 0.006 0.002 0.006 0.004 0.002  
LV546 0.023 0.038 0.023 0.021 0.021 0.023 0.042 0.021 0.021 0.006 0.004 0.004 0.000 0.004 0.002 0.000 0.002 
  L. tropica with L. tropica 
  L. aethiopica with L. aethiopica 
  L. tropica with L. aethiopica  
75 
 
Figure 4.5 is a graph showing the Distance Pairwise Comparison of L. tropica and L. 
aethiopica isolate RPL23a sequences to the L. tropica isolate LV1.  The distance results 
for the LV13 and LV697 L. tropica isolates are higher when compared to the other L. 
tropica parasites, and are higher than the result for L. infantum and L. donovani.  The 
difference values are higher than that of L. infantum and L. donovani in Table 4.4; 
however, they are still lower than the distance value for L. tropica and L. major. 
 
Figure 4.5. Graph of Pairwise Distance for RPL23a L. tropica and L. aethiopica 
Isolates against LV1 (L. tropica) with Pairwise Distance for L. infantum and L. 





















Leishmania Parasite Isolate ID
L. donovani and L. infantum
L. tropica and L. major
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4.2. Dot Blot for Viral dsRNA 
Dot blots were used to identify the presence of the dsRNA virus in different isolates of 
Leishmania.  Isolates were tested in batches of two to five with a positive and negative 
control each time.  The positive control was L. guyanensis M4174 and the negative 
control was L. major LV39.  A dot blot using the controls at different concentrations is 










Figure 4.6 Dot blot of positive, M4147, and negative, LV39, control isolates M4147 at 
three concentrations.  Membrane after Ponceau Red post stain on the right. 
 
The image shows the positive and negative controls at three concentrations.  The image 
of the gel before the Ponceau red stain shows the difference between the two parasites.  
The image on the left shows the Ponceau red stain and shows the presence of the 
negative control, supporting the accuracy of negative results.  The positive and negative 
controls were used in all of the dot blots performed to increase the reliability of the 
experiments as it shows the dot blot has worked properly.  The results were tested with 

























After Ponceau Red 
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dsRNA MAB J2 (Ig2a) antibody to find the concentrations that best showed the positive 
control without over saturating the negative control. 
The collection of L. aethiopica and L. tropica parasite isolates were tested for the 
presence of the RNA virus in groups of two to four.  Figure 4.7 illustrates a typical 
experiment and shows four Leishmania isolates being testing for the virus alongside the 







Figure 4.7 Dot blot showing positive and negative controls with samples testing 
positive and negative.  Post stain with Ponceau red is shown below.  
 
Figure 4.7 shows the positive and negative controls and four parasite isolates being 
tested for the virus.  Two of the isolates are positive and two are negative.  The Ponceau 
red stain shows that all isolates were present and that the negative results were not due 
to the protein being washed off the membrane.  As shown in Figure 4.7, some results 
show up very faintly on the dot blot, LV1 and LV142 in the case of the dot blot shown; 
however, these are counted as a negative result as they are distinctly different from the 
positive control.  The dot blots for all L. tropica and L. aethiopica isolates tested can be 
seen in Appendix IV.  All positive results were repeated after all the Leishmania 
parasite isolates were tested. An overview of the results of the dot blot for the RNA 

































Isolate Original ID RPL23a ID ITS1 ID dsRNA Virus 
LV357 L. tropica L. tropica (457) L. tropica (308) Negative 
LV510 L. tropica L. tropica (457)   
LV508 L. tropica L. tropica (457) L. tropica (308) Negative 
LV697 L. aethiopica L. tropica (458) L. tropica (313) Negative 
LV142 L. tropica L. tropica (457)  Negative 
SU23 L. tropica L. tropica (458)  Negative 
LV13 L. aethiopica L. tropica (457) L. tropica (313) Negative 
LV1 L. aethiopica L. tropica (459) L. tropica (306) Negative 
LV369 L. tropica L. tropica (458) L. tropica (308) Negative 
LV509 L. tropica L. tropica (458) L. tropica (308) Negative 
LV487 L. tropica L. tropica (457) L. tropica (308) Negative 
LV444 L. tropica L. tropica (457) L. tropica (308) Negative 
LV489 L. tropica L. tropica (457) L. tropica (308) Negative 
LV488 L. tropica L. tropica (457) L. tropica (308) Negative 
LV490 L. tropica L. tropica (457) L. tropica (308) Negative 
     
LV27 L. aethiopica L. aethiopica (460) L. aethiopica 
(324) 
Positive 
LV377 L. aethiopica L. aethiopica (460) L. aethiopica 
(327) 
Negative 
LV546 L. aethiopica L. aethiopica (460) L. aethiopica 
(326) 
Negative 
LV29 L. aethiopica L. aethiopica (460)  Negative 
LV472 L. aethiopica L. aethiopica (460) L. aethiopica 
(325) 
Negative 
LV28 L. aethiopica L. aethiopica (460) L. tropica (308) Negative 
LV26 L. aethiopica L. aethiopica (460) L. aethiopica 
(327) 
Positive 
LV15 L. aethiopica L. aethiopica (460) L. aethiopica 
(330) 
Positive 
LV25 L. aethiopica L. aethiopica (460) L. aethiopica 
(327) 
Negative 
Table 4.6 – Table of all leishmania isolates with original, RPL23a and ITS1 IDs and 




The percentage of positive and negative results of the viral dsRNA presence for both L. 
tropica and L. aethiopica is shown in Figure 4.8.  
 
Figure 4.8. The percentage of L. tropica and L. aethiopica parasites that were found 
positive and negative for the Leishmania RNA Virus in this study and others. 
The graph shows that 100% of the L. tropica parasite isolates tested were negative for 
the virus.  The L. aethiopica parasite isolates on the other hand had positive and 
negative results, with 33.3% testing positive for the virus.  Figure 4.8 also shows the 
percentage of L. aethiopica that have previously been found positive or negative for 
LRV in a study by Zangger et al. in 2014.  In that study 45% of L. aethiopica parasite 
isolates tested were found positive for the presence of LRV.  The graph in Figure 4.8 
also shows that the overall percentage of L. aethiopica isolates tested that were found 
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This Study, 14 isolates This Study, 9 isolates Zangger et al. 2014, 11
isolates
Combined, 20 isolates









L. tropica and L. aethiopica Isolates Tested for the Presence of the 
Leishmania RNA Virus in this study and other
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Chapter Five: Discussion  
The main aim of this study was to investigate the relationships between Leishmania 
aethiopica and L. tropica using a molecular approach with DNA sequence analysis and 
a biological approach regarding the presence of Leishmania viruses. For the molecular 
approach PCR was used to sequence the ITS1 products of L. aethiopica and L. tropica 
parasite isolates, and the results were presented in phylogenetic trees.  The phylogenetic 
tree in Figure 4.2 generated from the ITS1 primer PCR results from this study shows a 
strong branch point separating the parasite isolates identified as L. aethiopica.  The 
results of the PCR with ITS1 primers supported the findings from a PCR performed 
with RPL23a primers and indicated that three parasite isolates that were originally 
identified as L. aethiopica are actually L. tropica.  The phylogenetic tree of the RPL23a 
primer PCR product in Figure 4.3 also shows a strong branch point between the parasite 
isolates identified as L. tropica and L. aethiopica.  This provides further support that L. 
tropica and L. aethiopica are two clear biological entities. 
Within the L. tropica and L. aethiopica groups there is further branching; however, 
there is little correlation for this branching generated by the ITS1 and RPL23a 
sequences.  The bootstrap values for the in-group branching vary. This is not surprising 
because these sequences chosen for their ability to discriminate at the species level are 
not generally used for population level analysis. Microsatellite sequencing would 
provide greater insight and accuracy into the branching within the species; however, 
these sequences are often species specific and would not provide the phylogenetic 
analysis needed for this study. 
The phylogenetic patterns for both the ITS1 and RPL23a PCR products support each 
other's identification of the isolates as L. tropica and L. aethiopica; however, this does 
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not fully determine that L. tropica and L. aethiopica are two different species of 
Leishmania.  The bootstrap values on the phylogenetic trees can provide some 
indication of the difference between the L. tropica and L. aethiopica isolates, but does 
not indicate if they are sufficiently different to be classed as different species.  It is 
unclear where to draw the line to classify them as different species, and the percentage 
difference between the nucleotides of isolates identified as L. tropica and L. aethiopica 
would provide additional insight.  Tests for distance pairwise were performed to help 
determine this. 
Distance pairwise tests were performed on isolates from pairs of Leishmania species 
whose relationship is more established to give calibration to these data.  The pairs used 
were L. tropica and L. major, and L. donovani and L. infantum.  The species L. tropica 
and L. major are known to cause very similar clinical diseases, yet are significantly 
different biologically, with different sand fly vectors and reservoirs.  The Leishmania 
species L. donovani and L. infantum meanwhile are thought to be much more closely 
related.  The use of these pairs of Leishmania in the distance pairwise test for the L. 
tropica and L. aethiopica parasite isolates provides examples of the distance between 
two closely related species and two more distant species. 
The distance pairwise for the ITS1 results can be seen in Table 4.3 and Figure 4.4.  The 
distance pairwise results in Table 4.3 show that when comparing an L. tropica isolate 
to the other L. tropica isolates the distance values are generally low, apart from those 
for the isolates LV508 and LV509.  With the exception of those two isolates, the 
distance values are lower than those for both L. infantum vs L. donovani and L. tropica 
and L. major in Table 4.2.  These results indicate that the isolates are the same species 
of Leishmania.  The distance pairwise results show that when comparing an L. 
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aethiopica isolate to other L. aethiopica isolates the distance values are low, with the 
exception of LV28.  These values are lower than both of the distance pairwise values 
for the control Leishmania pairings in Table 4.2.  This would indicate that these isolates 
are of the same species.  The distance pairwise results for the ITS1 sequence of L. 
tropica and L. aethiopica isolates shows that there is a higher distance value when 
comparing an L. aethiopica against an L. tropica relative to when comparing like with 
like.  These distance values are higher than that of the L. infantum against the L. 
donovani in Table 4.2.  This contributes to the impression that the isolates are from 
different species.  The exception for this is the L. aethiopica isolate LV28. 
All of the distance values are below that for L. tropica and L. major; this includes the 
isolates that contrast with the rest of the results, LV28, LV508 and LV509.  The L. 
tropica isolates LV508 and LV509 were found to be very similar to each other when 
compared, and even though they had a higher difference from the other L. tropica 
isolates they had an even higher difference when compared to the L. aethiopica isolates.  
This indicates that they are more like L. tropica than L. aethiopica.  The two isolates 
are from Iraq and possibly taken from the same area at the same time, and so it is 
possible that their difference from the L. tropica isolates is due to a microsatellite 
expansion that they have in common.  The L. aethiopica isolate LV28 on the other hand 
has a lower difference from the L. tropica isolates than the other L. aethiopica isolates.  
This indicates that the isolate might be an L. tropica.  This would support the findings 
from the identification and phylogenetic tree of the PCR products. 
The pairwise distances for the RPL23a sequence of L. tropica and L. aethiopica parasite 
isolates is shown in Table 4.5 and Figure 4.5.  When comparing an L. aethiopica isolate 
to the other L. aethiopica isolates the pairwise distance value is very low; lower than 
both L. infantum vs L. donovani difference and L. tropica and L. major difference in 
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Table 4.4.  This would indicate that the isolates are of the same species.  This is also 
the case when comparing an L. tropica isolate to the other L. tropica isolates, with the 
exception of the isolates LV13 and LV397.  These isolates were originally identified as 
L. aethiopica but were identified as L. tropica from the PCR of the RPL23a and ITS1 
products.  The pairwise distance when comparing the two isolates together is very low.  
The distance value when comparing the L. aethiopica isolates against the L. tropica 
isolates is higher than when comparing isolates identified as the same species, and 
higher than the pairwise distance value for L. infantum and L. donovani.  This includes 
the LV13 and LV397 isolates.  This indicates that L. tropica and L. aethiopica are 
different species. 
The distance pairwise results for both the ITS1 and RPL23a products generally support 
the phylogenetic results.  The results indicate that the Leishmania species L. tropica 
and L. aethiopica are more significantly different than those of L. donovani and L. 
infantum, but are more similar than L. tropica and L. major.  The results for both 
sequences have some outliers, but only LV28 contradicts expectations. 
The L. aethiopica isolate LV28 has been identified as L. tropica through the PCR of the 
ITS1 sequence.  The isolate also grouped as L. tropica in the phylogenetic tree of the 
sequence, and the results of the distance pairwise test show the isolate to be closer to 
the L. tropica isolates than the other L. aethiopica isolates.  All these results would 
indicate that the isolate has been misidentified; however, previous PCR work on the 
isolate with the RPL23a sequence identifies it as an L. aethiopica.  The most likely 
explanation for this would be a mix up with the culture of the isolate at some point.  
Since this study, the isolate has been retested.  A repeat of the PCR with the ITS1 
primers showed the isolate as a L. tropica again.  A repeat of the PCR for the RPL23a 
sequence provided inconclusive results, indicating a mixture.  Earlier work on the 
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isolate showed it to be L. aethiopica.    The possible explanations for the results for this 
isolate are misidentification when the isolate was originally collected; a mix up of the 
culture at some point between its collection and this study; or a problem with the 
experimental method.  These results indicate that there has been a mix-up or 
contamination of the isolate at some point.  It should be noted that these isolates were 
originally deposited in the cryobank in the 1970s, at that time held in the Liverpool 
School of Tropical Medicine. To resolve the identification earlier or alternative (from 
another cryobank) samples of the isolate need to be tested. 
Other results from this study that need to be examined are the isolates that were 
originally identified as L. aethiopica but the results consistently returned as L. tropica.  
These isolates, LV1, LV13 and LV697, were identified as L. tropica by the PCR of 
both the ITS1 and RPL23a sequences.  There are a few possible explanations for these 
results.  Firstly, it is also possible that these isolates were misidentified when first 
collected.  All the isolates came from Ethiopia, and so it is possible that they were taken 
at the same time as other L. aethiopica isolates and were presumed to be the same; as 
PCR sequencing on samples was not possible at the time.  Another significant 
possibility is that the isolates were originally L. aethiopica but at some point between 
collection and these studies there was a mix up or contamination of the cultures with L. 
tropica samples.  There are other possible explanations, such as the isolate being a 
hybrid of the two species; however, this is less likely.  One study used a fluorescence 
resonance energy transfer (FRET)-based real-time PCR assay to differentiate between 
L. tropica, L. aethiopica and L. major (Nath-Chowdhury et al. 2016).  The three species 
were readily differentiated based on their melting curve characteristics.  The study 
identified LV13 as L. aethiopica.  This indicates that the isolate was originally 
accurately identified as L. aethiopica and suggests that the sample used in this study 
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may have been subject to a mix up or contamination of the culture, although this is not 
for certain.  A study by Zelazny in 2005 which evaluated the use of the 7SL RNA gene 
sequence for the identification of Leishmania species identified LV1 as an L. 
aethiopica; however, the results of the PCR found L. aethiopica, L. tropica, L. major 
and L. mexicana sequences to be the same length, and the L. tropica and L. aethiopica 
to be very close on the phylogenetic tree.  A study in 2011 by Odiwuor used PCR of 
the ITS1 sequence on Old World species of Leishmania.  In this study, LV1 was 
identified as L. tropica.  These results support the ITS1 results of this study and the 
RPL23a findings.  This could indicate that the sample was originally miss identified as 
L. tropica, although this cannot be said for certain. 
Misidentification of L. tropica isolates as L. aethiopica upon collection could be due to 
the assumed species present at the site.  The two species of Leishmania are now known 
to have some overlap in geographical incidence.  One possible explanation for the 
presence of L. tropica in areas of Africa where L. aethiopica is found is the impact of 
climate change on the distribution of species.  In the 2014 report of the 
Intergovernmental Panel on Climate Change (IPCC) it is stated that climate change will 
affect human health through the exacerbation of already existing health problems 
(Woodward et al. 2014).  One way in which Leishmania may be affected by climate 
change is through its vectors. Vector borne diseases are particularly susceptible to 
climate change (Woolhouse et al. 2001).  This is because the species distribution is 
related to climatic variables (Carvalho et al. 2015), and so vector species with a 
distribution based on climatic variables may experience a shift in distribution when 
those variables change (Parham et al. 2015).  Leishmaniasis is a climate sensitive 
disease (Ready, 2008), and sand flies behaviour and distribution being affected by 
temperature, rainfall and humidity is a large factor in this (Carvalho et al. 2015).  It has 
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been observed that cutaneous leishmaniasis has expanded beyond its natural ecoregion, 
particularly in North Africa and regions of the Middle East, areas where significant 
environmental changes have occurred (Bounoua et al. 2013).  Cutaneous leishmaniasis 
has spread from northwards from the Algerian arid zones and towards the semi-arid 
areas.  Zoonotic cutaneous leishmaniasis in this region caused by L. major is the 
dominant infection (Alvar et al. 2012).  Tt has been suggested that climate change and 
desertification observed in the northern Sahara has had a role in this expansion of the 
disease (Mcdowell et al. 2011).  Cutaneous leishmaniasis is also rapidly spreading 
across Morocco (Bounoua et al. 2013).  Climate change is known to have an impact on 
vector borne diseases and is thought to have had an impact on the incidence of zoonotic 
cutaneous leishmaniasis caused by L. major; it is possible that changes in the climate 
has had an impact on the distribution of cases of L. tropica.  Furthermore, increased 
understanding of the impact of climate change on vector distribution is vital for the 
understanding of the eco-epidemiology of leishmaniasis; and for the success of 
surveillance and control implementations (Carvalho et al. 2015). 
Leishmania viruses were originally described some time ago, but have received more 
recent attention as a potential contributor to pathology of leishmaniasis. Currently it is 
not clear whether these are restricted to certain species of Leishmania. In this study the 
presence of LRV in the L. tropica and L. aethiopica isolates was tested for using a dot 
blot with a monoclonal antibody specific for double-stranded RNA.  The results of the 
dot blots are summarized in Table 4.6.  The dot blot assay found that none of the L. 
tropica isolates were positive for the presence of the virus, and the species has not 
previously been found to be positive.  Three of the L. aethiopica isolates tested in this 
study tested positive for the presence of LRV. Other L. aethiopica isolates have 
previously been tested and some found positive for the virus by Zangger in 2013.  One 
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of the L. aethiopica isolates tested in this study has previously been tested for LRV, and 
was found to be negative for the virus in both studies.  The Leishmania parasites found 
positive for the virus in this study were not tested previously.  Figure 4.8 shows the 
percentage of L. aethiopica isolates that have been found to be positive for the presence 
of LRV in this study and those previously performed.  The combined results show that 
the RNA virus is present in 40% of L. aethiopica isolates tested so far. 
LRV being found present in L. aethiopica but not L. tropica parasites is evidence of a 
further difference between the two, supporting that they are different species.  The LRV 
results indicates that there might be a biological difference between L. tropica and L. 
aethiopica. 
The aims of this study were to look into the relationship between L. tropica and L. 
aethiopica, as well as to look for the presence of the Leishmania RNA Virus in these 
species.  The results of the PCR on the ITS1 sequences reinforce findings that L. tropica 
and L. aethiopica are two different species.  This is also shown in the phylogenetic trees 
for both the ITS1 and RPL23a products where the L. tropica and L. aethiopica isolates 
split into two distinct groups.  This is further supported by the distance pairwise results 
for the two sequences.  The results of this test showed that the difference between the 
L. tropica and L. aethiopica isolates is greater than when comparing like with like.  The 
results also showed that the two species are more different than L. donovani and L. 
infantum, supporting the different species concept; however, the results also showed 
that the species are more similar than L. tropica and L. major.  This would indicate that 
the species are closely related. 
The results of the dot blot contributed to evidence of the Leishmania RNA Virus being 
present in the L. aethiopica species.  The combined results of this study and others 
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indicate that it is present in approximately 40% of the species, although more isolates 
should be tested to support this.  The presence of LRV was not detected in the L. tropica 
species.  The presence of the virus in L. aethiopica isolates but absent from all L. tropica 
isolates tested introduces another difference between the two and adds support to the 
two being different species. 
Both the PCR sequencing and the dot blot for the viral RNA were effective for 
answering the aims of this study.  The PCR was a relatively quick way to identify and 
classify the parasite species, and the method provided data that could be used in several 
evaluations.  PCR is a useful technique for the sequencing of DNA.  It has a high 
sensitivity for the detection of a specific DNA sequence in a sample.  In this study, PCR 
was used for identification and classification of Leishmania parasite isolates.  The 
results of the PCR were used in several ways in this study.  Sequences were identified, 
made into phylogenetic tress with bootstrapping and different outgroups; pairwise 
distance evaluated against two pairs on known species; and all assays compared to the 
sequences for the RPL23a sequence.  The PCR successfully helped to identify the 
isolates as L. tropica or L. aethiopica and phylogenetic trees were generated from the 
sequences, and demonstrated two data sets.  The PCR successfully aided in classifying 
the species, and also in determining if they should be classified as different species.  
Comparing the PCR of the ITS1 sequence to the PCR of the RPL23a sequence and 
analysing both sets of data provided additional substance to the results as the data sets 
generally supported each other. 
The sequence used in this study, ribosomal DNA internal transcribed spacer 1 (ITS1), 
is a commonly used sequence when working with Leishmania.  The wide use of the 
sequence in molecular phylogeny and taxonomy is due to several favorable features of 
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the gene.  The sequence can be amplified with PCR using universal primers.  The gene 
undergoes rapid concerted evolution which promotes inter-genomic homogeneity of the 
ITS paralogues.  Due to the high copy number of rDNA clusters, the sequence can be 
detected even in small quantities of DNA.  The gene has a high degree of variation, 
even between closely related species (Baldwin et al. 1995), making it an appropriate 
target for the PCR in this study.  Despite the advantages of the ITS1 gene, there are also 
drawbacks in its use.  Although the gene is very good for pure identification, the ITS1 
gene can be misleading for phylogenetic purposes.  ITS1 is from a multigene family, 
and a change in one copy can spread throughout the genome.  Because of this, large 
changes can occur.  An ideal phylogenetic marker evolves at a steady rate through time, 
and so the amount of change or degree of difference between two markers directly 
correlates to how far and how long they have been separated.  This is the basis that a 
reliable phylogenetic tree is built on.  The large changes from random events that can 
occur in the ITS1 gene can be compromising when generating a good map of 
phylogeny. 
The sequences for the PCR used in this study did not provide highly accurate insight in 
group branching.  A microsatellite sequence approach would be more appropriate for 
this; however those tend to be species-specific and would not have helped in 
determining the classification of the L. tropica and L. aethiopica isolates in respect to 
each other.  Microsatellite sequencing could add insight into the L. tropica isolates 
LV508 and LV509, and the length of their sequences and results from the distance 
pairwise indicate that there might have been a microsatellite expansion. 
The PCR method and the sequences used were appropriate for achieving the aims of 
this study.  All results of the PCR support that L. tropica and L. aethiopica are different 
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species with exception of the L. aethiopica isolate LV28.  Furthermore, the results for 
the L. aethiopica isolate LV28, and the misidentified isolates, demonstrate the 
importance and value of the PCR method.  If the results are due to a prior culture mix 
up, it exhibits how important it is to ensure the sample is accurate, and how PCR is an 
effective and accessible method to achieve this.  Although the PCR provided various 
data that supports L. tropica and L. aethiopica being different species, it cannot 
definitively determine that they are so. 
One of the main steps that would need to be taken next would be to re-examine the 
isolates that returned unexpected or contradictory results, LV1, LV13, LV697 and 
LV28, with LV28 taking the highest priority.  All of these isolates should be re-assayed 
with PCR of both the ITS1 and RPL23a sequences.  The PCR should be run for both 
recent and older samples of the isolates.  If possible, other laboratories with the isolates 
could be contacted.  This could help indicate if the isolates have been contaminated or 
mixed at some point.    
The dot blot method used in this study was successful for detecting LRV in the 
Leishmania parasite isolates tested.  It was only used to check for the presence of the 
virus in L. tropica and L. aethiopica isolates used in the PCR.  This study did not assess 
the amount of the virus that was present, and the method does not provide insight into 
the ability of the parasite to gain or lose the virus in culture or over the course of 
infection.  These are possible areas for future research into LRV.  The dot blot in this 
study found that a third of the L. aethiopica isolates tested had presence of LRV, which 
supports previous findings by Zangger (2013); and found all of the L. tropica isolates 
tested to be negative for the presence of the virus.  These findings provide further 
evidence of a difference between L. tropica and L. aethiopica, supporting the results of 
91 
 
the PCR that they are two species.  This shows that not only was the dot blot an 
appropriate method for the aim of the study to detect LRV, but also contributed to the 
aim of study to investigate the relationship between L. tropica and L. aethiopica. 
The results for the dot blot have the helped to increase knowledge of which species 
carry LRV.  As the virus has strong links to an increased pathology of leishmaniasis 
understanding which species of Leishmania can carry the virus is important.  The 
knowledge could be used to provide increased care needed in areas affected by this 
species due to increased risk of mucosal complications. 
An area of further research could be in the relationship between the Leishmania RNA 
virus and the Leishmania parasites.  Further research could help determine whether the 
presence of LRV is a benefit or a detriment to the parasite, or if it simply acts as a silent 
partner.  There is a high possibility that the presence of the virus in the Leishmania has 
some cost to the parasite; however, if the cost is small then the virus may potentially be 
a benefit for the parasite.  LRV has links to increased pathology of leishmaniasis.  It is 
possible that the increase in lesions on the host attracts the sand fly vectors, and so 
improving the transmission of the Leishmania parasite.  There have been many reports 
that parasite presence in a host can lead to transmission in various ways.  It has been 
shown that mosquitoes have a greater feeding success when exposed to mice infected 
with malaria due to the impairment of the host’s defensive behavior (Day and Edman, 
1983).  It has been observed that female sand flies were more attracted to hamsters that 
were infected with L. infantum possibly due to the odour of the host (O’Shea et al in 
2002). Coleman and Edman (1988) studied the feeding of sand flies on cutaneous 
lesions caused by Leishmania.  They concluded that there was a positive correlation 
between the probing and feeding and the location of the lesions, although the initial 
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landing of the sand fly was random.  A possible future study to investigate a correlation 
between the presence of the virus and increased transmission would be observing the 
feeding of the sand flies and transmission of the parasite with mice, comparing the 
results for Leishmania with and without the presence of LRV. 
If an increase in pathology does lead to an increase in transmission, the presence of 
LRV in Leishmania would be advantageous to the parasite.  It has already been seen 
that LRV is only found in some Leishmania species.  A continuation of this study would 
be to test other species of Leishmania for presence of the Leishmania RNA virus.  This 
would help to develop an understanding of why some species have the virus and some 
do not, in addition to providing a greater understanding of the role of the virus in the 
pathology of the disease.  Furthermore, if more Leishmania species are tested for 
presence of LRV then the pattern of how the virus is distributed could be analysed.  
RNAi is only expressed in some species of Leishmania.  The species that do express 
RNAi activity include L. braziliensis and L. guyanensis, species that LRV1 is present 
in.  RNAi usually controls RNA viruses infecting the organism, yet it appears that 
LRV1 is able to survive in its presence.  Despite this, further research into the 
interaction of RNAi and LRV in species of Leishmania where both are present has the 
possibility to lead to the use of RNAi to generate LRV-free isogenic isolates. 
Another potential area to investigate would be the impact on immunity in areas affected 
by Leishmania species with LRV.  As the virus is thought to increase the pathology of 
the disease, this could potentially lead to an increase in immunity in the populations of 
these areas.  This could be investigated by documenting cases of infection and immunity 
in areas where strains of Leishmania that are known to be infected with LRV are 
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prevalent and comparing with regions were species that have not yet been found to 
contain the virus are dominant. 
In addition to investigating any beneficial aspect of the presence of the virus for the 
parasite, other aspects of the relationship between the virus and the parasite need to be 
explored.  Areas of their relationship that could be looked into include how the parasite 
acquires the virus and the potential to lose it.  Totiviridae viruses, such as the 
Leishmania RNA Virus, like most others of the family, are typically neither infectious 
nor shed, and so are generally only inherited vertically or during genetic exchange.  This 
raises the question of how the parasites gain the virus in the first place.  The diversity 
of species of Leishmania are thought to have arisen primarily through the gradual 
accumulation of divergent mutations, rather than through sexual recombination.  
However, despite its presumed infrequency in nature and experimentally, genetic 
exchange does occur.  There have been many examples of genetic hybridization in field 
isolates involving most Leishmania species, and it is possible that they have occurred 
though mating events.  In this case, it could be possible for one of the parasites to have 
the virus, and so pass it to any offspring.  A possible future study would be a comparison 
of Leishmania species that have been found to have the presence of LRV and the species 
that are known to exhibit genetic exchange.  It is also possible that LRV can also be 
horizontally transmitted, but that it occurs rarely or at a lower rate than has been 
detected. Another point of interest is the potential loss of the virus.  It has been observed 
(Ro et al. 1997) that an isolate with LRV can be cultured to produce a strain that no 
longer has the virus, although this was achieved by drug selection and not obtained 
through culture alone.  In culture conditions the virus can only undergo vertical 
transmission.  The culture medium is high in nutrients, and so the parasites grow and 
replicate faster than they would normally.  Due to this the growth rate of the parasites 
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could be greater than the replication rate of the virus.  There are other areas around the 
infection of LRV that could be investigated.  The fluctuation and amount of virus 
present over the course of an infection could be examined.  As LRV appears to be 
mostly limited to vertical transmission, it is likely that there is a limit to how much it 
will replicate.  If there is no common spreading mechanism, the virus replicating to the 
point it is detrimental to its host will harm the virus too.     
For L. aethiopica, half of isolates from fresh clinical samples tested were positive for 
the virus, and less than half when testing isolates from a cryo-bank.  An area for further 
study would be testing more fresh clinical Leishmania isolates for LRV as this could 
provide additional insight into the relationship between the parasite and the virus.  The 
Leishmania parasite could be attempting to get rid of the virus, or is it purely random 
whether the parasite has the virus or not.  Moreover, knowing which species of 
Leishmania may have the virus could also mean that the areas where the species is 
prevalent need more clinical care and preventative measures against the parasite. 
In summary, this work has shown L. tropica and L. aethiopica to be different species.  
The results of the PCR for the ITS1 product were used to identify the isolates, map them 
phylogenetically and were compared to the results of the RPL23a sequences.  The 
results were also used in a distance pairwise assay to observe the significance of the 
difference between the two species.  All of these results support L. tropica and L. 
aethiopica as different species.  The results of the dot blot showed that the Leishmania 
RNA Virus is present is some L. aethiopica isolates but has not been found in L. tropica.  
These results are consistent with previous findings, and also support that L. tropica and 
L. aethiopica are different species. 
95 
 
There are many areas for future investigation related to this study.  The priority is to 
repeat the PCR for LV28 using different sequences with new and old isolates to try and 
determine whether the isolate has been misidentified in the past or has become 
contaminated more recently.   In addition to this, key areas for future research include 
testing more species for the presence of LRV; to examine biological differences 
between L. tropica and L. aethiopica investigating the relationship between LRV 
presence, the rate of transmission, and immunity in the affected population; and the 
spreading mechanism of LRV between parasites.  A more complete list of which species 
of Leishmania can carry the virus will help improve the understanding of the role of 
LRV and how it interacts with the Leishmania parasites.  As the virus is linked to 
increased pathology, the knowledge could also be used to promote aid in the areas that 
are affected by Leishmania species that carry LRV.  The results of the dot blot showing 
L. aethiopica isolates can contain LRV but no evidence that L. tropica can carry the 
virus indicates that there may be a possible biological difference.  If this is found then 
it could conclusively determine whether L. tropica and L. aethiopica are indeed 
different species.  Developing a greater understanding of the spreading mechanism of 
LRV could help develop treatment or prevention against the highly pathogenic disease 
the virus is associated with.  Examining the relationship between LRV and the rate of 
transmission of leishmaniasis will help understand whether the virus is overall 
beneficial for the Leishmania parasite, and could explain its presence.  Finally, 
investigating the effect of LRV presence in Leishmania on the level of immunity in the 
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Appendix I - List of ITS-1 sequences 
DNA sequences produced from PCR with the ITS1 primers on L. tropica and L. 
aethiopica isolates, with L. major and L. guyanensis. 
 






























































































































































































Appendix II - List of RPL23 sequences 
RPL23a DNA sequences for L. tropica and L. aethiopica, L. major, L. donovani, L. 
infantum and L. guyanensis isolates.  The sequences were generated by Godwin 
Kwakye –Nuako; L. major LV39, L. guyanensis M4147, L. aethiopica LV25 and 
LV546 and L. tropica LV357 were repeated in this study. 
 
 




































































































































































































































































































Appendix III – Phylogenetic Trees 
Phylogenetic tree with bootstrapping of ITS 1 sequence for L. tropica and L. 






Phylogenetic tree of ITS 1 sequence for L. tropica and L. aethiopica with L. infantum 





Phylogenetic tree with bootstrapping of RPL23a sequence for L. tropica and L. 












Phylogenetic tree with bootstrapping of RPL23a sequence for L. tropica and L. 





Appendix IV – Dot Blots 
 















LV1, LV15, LV26 and LV142 with positive and negative controls before and after 


























































































LV13, LV375, LV25 and LV546 with positive and negative controls before and after 
Ponceau Red stainingLV13, LV375, LV25 and LV546 with positive and negative 















LV28, LV29, LV472, LV369 and LV508 with positive and negative controls before 



















































































































































LV27, LV29, LV697, LV444 and SU23 with positive and negative controls before 
















LV377 and LV489 with positive and negative controls before and after Ponceau Red 
staining 
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